{"study_id": 2921, "supplement_id": 893, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to assess the safety, efficacy, and tolerability of Ashwagandha root extract in improving general health and sleep quality in elderly individuals.", "results_summary": "The study found statistically significant improvements in quality of life, sleep quality, and mental alertness in the Ashwagandha group compared to placebo, with good tolerability and no reported safety concerns.", "population_specificity": "Elderly individuals aged 65-80 years of either gender.", "effective_dosage": "600 mg/day orally.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:01.784594+00:00"}
{"study_id": 2919, "supplement_id": 893, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess and summarize the current state and implications of Ashwagandha in treating various brain disorders, focusing on its neuroactive phytoconstituents, pharmacological effects, and mechanistic pathways.", "results_summary": "The study identified multiple neuroprotective phytoconstituents in Ashwagandha with potential benefits for brain disorders such as anxiety, Alzheimer's, and Parkinson's, supported by preclinical studies and patents. However, clinical data on mechanistic pathways and efficacy remains scarce and inconclusive.", "population_specificity": "Not specified (broad focus on brain disorders in general).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:01.872303+00:00"}
{"study_id": 2920, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the active phytoconstituents, pharmacologic activities, mechanisms of action, potential applications, and safety profile of Ashwagandha (Withania somnifera).", "results_summary": "The study found that Ashwagandha exhibits a broad range of biological effects, including anti-cancer, anti-inflammatory, anti-diabetic, and neuroprotective properties, with potential benefits in reducing oxidative stress and inflammation. It also highlighted the role of Withaferin-A as a key phytoconstituent.", "population_specificity": "Not specified (general review of preclinical and clinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:02.769908+00:00"}
{"study_id": 2922, "supplement_id": 893, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the stress-relieving effects of high-concentration Ashwagandha root extract in stressed healthy adults, focusing on dose-response relationships.", "results_summary": "Ashwagandha significantly reduced perceived stress (PSS scores) and serum cortisol levels at both 250 mg/day and 600 mg/day doses, with greater effects at the higher dose. Participants also experienced significant improvement in sleep quality compared to placebo.", "population_specificity": "Stressed healthy adults (60 participants, male and female) with baseline PSS scores >20.", "effective_dosage": "125 mg or 300 mg twice daily (total 250 mg/day or 600 mg/day).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:03.985159+00:00"}
{"study_id": 2924, "supplement_id": 893, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy and safety of Ashwagandha root extract in improving sleep quality and reducing anxiety in patients with insomnia.", "results_summary": "Ashwagandha significantly improved sleep onset latency, sleep efficiency, sleep quality, and anxiety scores compared to placebo after 10 weeks of treatment. The study found no significant adverse effects, indicating good tolerability.", "population_specificity": "60 patients with insomnia and anxiety, randomly divided into test (n=40) and placebo (n=20) groups.", "effective_dosage": "300 mg of full-spectrum Ashwagandha root extract twice daily.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:04.350203+00:00"}
{"study_id": 2923, "supplement_id": 893, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the health benefits, safety, and mechanisms of action of Ashwagandha (Withania Somnifera), particularly its potential anti-carcinogenic properties.", "results_summary": "The study found that Ashwagandha has demonstrated benefits against various illnesses, including epilepsy, depression, arthritis, and diabetes, and shows potential as an anti-carcinogenic agent. Clinical trials indicated safety, and Withaferin A (WFA) exhibited cytotoxic activity against several cancers, though the exact mechanisms remain unclear.", "population_specificity": "Patients suffering from epilepsy, depression, arthritis, diabetes, and various cancers (breast, colon, prostate, ovarian, lung, brain).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:04.892940+00:00"}
{"study_id": 2904, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy of ashwagandha tea, alone or combined with matcha tea, in protecting against oxidative injury and cell death in the uterus and ovaries of female rats.", "results_summary": "Ashwagandha tea, along with matcha, improved biochemical and microscopic markers of oxidative injury and cell death in uterine and ovarian tissues, though the best improvement was observed in the matcha-administered group.", "population_specificity": "Adult female rats with induced utero-ovarian oxidative injury.", "effective_dosage": "100 mg kg\u207b\u00b9 b.wt. and 200 mg kg\u207b\u00b9 b.wt.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:05.846476+00:00"}
{"study_id": 2925, "supplement_id": 893, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the anxiolytic effects of Ashwagandha on adults with self-reported high stress and examine potential mechanisms related to its therapeutic effects.", "results_summary": "Ashwagandha supplementation significantly reduced anxiety (HAM-A) and stress markers (cortisol, DHEA-S) compared to placebo, with near-significant reductions in DASS-21. Testosterone levels increased in males but not significantly compared to placebo.", "population_specificity": "Stressed, healthy adults (n=60).", "effective_dosage": "240 mg of standardized Ashwagandha extract (Shoden) once daily.", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:06.658347+00:00"}
{"study_id": 2927, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-hypothyroidism potential of ashwagandha methanolic extract (AME) in a propylthiouracil-induced hypothyroidism animal model.", "results_summary": "AME significantly improved thyroid hormone levels (T3, T4), reduced oxidative stress markers, and enhanced thyroid gland histology, outperforming the standard anti-hypothyroidism drug in some measures. It also mitigated adverse metabolic and inflammatory changes induced by hypothyroidism.", "population_specificity": "Animal model (propylthiouracil-induced hypothyroidism)", "effective_dosage": "Not specified", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:09.922558+00:00"}
{"study_id": 2928, "supplement_id": 893, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of Ashwagandha (WSE) as an adjunctive treatment for depression and anxiety symptoms in patients with schizophrenia experiencing an exacerbation of positive symptoms.", "results_summary": "The study found medium effect sizes favoring Ashwagandha over placebo for reducing depression and anxiety symptoms in schizophrenia patients. Adverse events were mild and transient.", "population_specificity": "Patients with schizophrenia experiencing an exacerbation of positive symptoms.", "effective_dosage": "1,000 mg of standardized WSE.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:10.432351+00:00"}
{"study_id": 2926, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the stress resistance-promoting effects of triethylene glycol (TEG) and withanolide-free Ashwagandha root extract (WFWS) in mice.", "results_summary": "WFWS at doses up to 10 mg/kg/day was as effective as TEG in protecting against stress-induced changes in body weight, core temperature, and marble-burying behavior. Higher doses (33.3 and 100 mg/kg) also protected against stress-triggered alterations in blood glucose, insulin levels, and exhibited antidepressant or anxiolytic-like effects.", "population_specificity": "Mice subjected to foot shock stress and marble-burying tests.", "effective_dosage": "3.3, 10, 33.3, or 100 mg/kg/day of WFWS.", "study_duration": "12 consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:11.393881+00:00"}
{"study_id": 2930, "supplement_id": 893, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine if adjunctive treatment with a standardized Ashwagandha extract (WSE) improves psychopathology and stress in patients with schizophrenia or schizoaffective disorder.", "results_summary": "WSE significantly reduced PANSS negative, general, and total symptoms, as well as perceived stress, compared to placebo. CRP and S100B levels declined more in the WSE group but were not statistically significant. Adverse events were mild to moderate and transient.", "population_specificity": "Patients with schizophrenia or schizoaffective disorder experiencing symptom exacerbation.", "effective_dosage": "1,000 mg/d", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:12.368186+00:00"}
{"study_id": 2929, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Withaferin A and Withanone from Ashwagandha could restore wild-type p53 function in cancer cells harboring specific p53 mutations.", "results_summary": "The study found that Withaferin A, Withanone, and an extract rich in these withanolides selectively restored wild-type p53 function in p53Y220C mutant cells, leading to growth arrest and apoptosis. No significant effects were observed for other p53 mutations (p53V143A, p53R249S, p53R273H).", "population_specificity": "Human cancer cell lines with specific p53 mutations (p53V143A, p53R249S, p53R273H, p53Y220C).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:13.216536+00:00"}
{"study_id": 2932, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-inflammatory effects of Ashwagandha root hot water extract (ASH-WEX) on skin using human keratinocyte cells and mouse skin.", "results_summary": "ASH-WEX significantly reduced inflammatory cytokine expression (IL-8, IL-6, TNF-\u03b1, IL-1\u03b2, IL-12) and increased anti-inflammatory TGF-\u03b21 in HaCaT cells and mouse skin, likely by suppressing NF-\u03baB and MAPK pathways.", "population_specificity": "Human keratinocyte cell line (HaCaT) and mouse skin.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:13.885924+00:00"}
{"study_id": 2931, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of daily ashwagandha extract supplementation compared to placebo in subjects with nonrestorative sleep (NRS) over six weeks, as measured by the Restorative Sleep Questionnaire-weekly version (RSQ-W).", "results_summary": "The abstract does not provide specific results, but the study design suggests it will assess ashwagandha's impact on NRS using objective (actigraphy, polysomnography) and subjective (RSQ-W, HADS, WHOQOL) measures, along with inflammatory markers like C-reactive protein.", "population_specificity": "Individuals with nonrestorative sleep (NRS) identified using the RSQ-W questionnaire.", "effective_dosage": "Not specified in the abstract.", "study_duration": "42 days of medicine/placebo intake.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:14.177690+00:00"}
{"study_id": 2933, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antioxidant and apoptotic effects of Ashwagandha leaf extract on hepatocellular carcinoma (HCC) cells.", "results_summary": "Ashwagandha water extract (ASH-WX) demonstrated increased cytotoxicity, enhanced antioxidant activities, elevated Fas-ligand levels, and increased caspase-3, -8, and -9 activities while reducing TNF-\u03b1 levels in HepG2 cells. Molecular docking suggested strong binding to cyclin D1, and cell cycle analysis showed accumulation in G0/G1 and G2/M phases.", "population_specificity": "Hepatocellular carcinoma cell line (HepG2)", "effective_dosage": "6.25 mg/ml to 100 mg/ml (IC50 ~5.0 mg/ml)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:15.790126+00:00"}
{"study_id": 2934, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of Ashwagandha in improving male fertility by examining its effects on semen quality, oxidative stress, and hormonal balance.", "results_summary": "Ashwagandha improved sperm count and motility, reduced lipid peroxidation, and regulated reproductive hormone levels, though its molecular mechanisms remain unclear. The study suggests both direct (oxidative stress mitigation) and indirect (hormonal balance via GABA-like pathways) mechanisms.", "population_specificity": "Infertile men (human and animal studies referenced).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:17.495736+00:00"}
{"study_id": 2935, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to validate the effects of Kunapa jala (KJ) and Pancha gavya (PG) on the germination parameters of Ashwagandha and Kalamegha seeds compared to other treatments.", "results_summary": "KJ and PG showed good nutrient content and were effective in improving germination parameters, with KJ performing better than PG but both being outperformed by NPK.", "population_specificity": "Ashwagandha and Kalamegha seeds (plant-based study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:18.768733+00:00"}
{"study_id": 2936, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ashwagandha root extract exhibits analgesic effects in rat models of postoperative and neuropathic pain.", "results_summary": "Ashwagandha root extract significantly increased mechanical withdrawal thresholds and reduced pain-related behaviors in rat models, while also alleviating hyperalgesia and cytokine levels in neuropathic pain. The active compound withaferin A showed CCR2 antagonistic effects, suggesting a potential mechanism for pain relief.", "population_specificity": "Rat models (plantar incision and spared nerve injury)", "effective_dosage": "100 and 300 mg/kg", "study_duration": "15 continuous days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:19.072473+00:00"}
{"study_id": 2937, "supplement_id": 893, "safety_score": "85", "efficacy_score": 88, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of ashwagandha root extract in improving thyroid function in patients with subclinical hypothyroidism.", "results_summary": "Ashwagandha significantly improved serum TSH, T3, and T4 levels compared to placebo, with minimal and temporary adverse effects reported in a small fraction of participants.", "population_specificity": "Adults aged 18-50 with elevated serum TSH levels (4.5-10 \u03bcIU/L).", "effective_dosage": "600 mg daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:19.965136+00:00"}
{"study_id": 2938, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to determine if Ashwagandha root could ameliorate nonclassic 11-hydroxylase deficiency, building on prior findings of its effects on similar enzyme deficiencies.", "results_summary": "The study found that Ashwagandha root appeared to ameliorate nonclassic 11-hydroxylase deficiency, with effects that were dose-related. This is the first report of its use for this specific condition.", "population_specificity": "An elderly woman with acne and male pattern alopecia due to nonclassic 11-hydroxylase deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:20.706275+00:00"}
{"study_id": 2940, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of ashwagandha in improving memory and cognitive functioning in adults with mild cognitive impairment (MCI).", "results_summary": "The ashwagandha treatment group showed significant improvements in immediate and general memory, executive function, sustained attention, and information-processing speed compared to the placebo group. These improvements were supported by multiple validated cognitive tests.", "population_specificity": "Adults with mild cognitive impairment (MCI)", "effective_dosage": "300 mg twice daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:21.949492+00:00"}
{"study_id": 2941, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to identify the active sleep-inducing components of Ashwagandha leaves and evaluate their effects on sleep regulation in mice.", "results_summary": "The alcoholic extract of Ashwagandha was ineffective, but the water extract containing triethylene glycol significantly increased non-rapid eye movement sleep in mice. Commercially available triethylene glycol also showed dose-dependent sleep-inducing effects.", "population_specificity": "Mice", "effective_dosage": "10-30 mg/mouse of triethylene glycol", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:23.018827+00:00"}
{"study_id": 2943, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ashwagandha leaf extract (i-Extract) has cholinergic properties that counteract scopolamine-induced cholinergic deficits in mice.", "results_summary": "The study found that i-Extract attenuated scopolamine-induced disruptions in the cholinergic system, evidenced by restored acetylcholine levels and Arc gene expression. Biochemical and molecular analyses supported its cholinergic activity.", "population_specificity": "Scopolamine-induced amnesic mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:26.246184+00:00"}
{"study_id": 2942, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the bioactive components (Withanolides, Withaferin-A, and Withanone) in Ashwagandha leaves versus roots and explore hydroponic cultivation methods to optimize their content.", "results_summary": "The study found that Ashwagandha leaves contain higher levels of active Withanolides (Withaferin-A and Withanone) than roots. Hydroponic cultivation under manipulated light conditions yielded leaves with a high Withanone/Withaferin-A ratio, and cyclodextrin-based extracts were prepared to achieve desired ratios, suggesting potential value for cancer treatment.", "population_specificity": "Not specified (laboratory study, no human participants)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:26.393740+00:00"}
{"study_id": 2945, "supplement_id": 893, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the safety and efficacy of a standardized Ashwagandha root extract for reducing stress and aiding body weight management in adults under chronic stress.", "results_summary": "Ashwagandha significantly improved primary (stress and food cravings) and secondary (happiness, eating behavior, cortisol levels, body weight, and BMI) measures. The extract was found to be safe and tolerable.", "population_specificity": "52 adults under chronic stress.", "effective_dosage": "300 mg twice daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:27.392845+00:00"}
{"study_id": 2944, "supplement_id": 893, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the efficacy and safety of Withania somnifera (Ashwagandha) root extract as an adjunct therapy to SSRIs in treating OCD.", "results_summary": "The study found that Ashwagandha significantly reduced OCD symptom severity compared to placebo, as measured by the Y-BOCS scale, with no reported adverse events. The extract was deemed safe and effective as an adjunct to SSRIs.", "population_specificity": "Thirty patients with a confirmed DSM-IV-TR diagnosis of OCD, all under SSRI treatment.", "effective_dosage": "120mg/day (4 capsules daily, preferably after meals).", "study_duration": "Six weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:27.777958+00:00"}
{"study_id": 2946, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether ashwagandha could mitigate inflammation induced by TNF-\u03b1 and LPS in vitro, specifically focusing on its potential to attenuate chemokine expression (CCL2 and CCL5) and NF-\u03baB activation.", "results_summary": "Ashwagandha water-soluble extract (WSE) completely prevented TNF-\u03b1-induced increases in CCL5, attenuated CCL2 expression and NF-\u03baB activation, and showed similar protective effects against LPS-induced inflammation.", "population_specificity": "In vitro study (cell-based model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:29.251351+00:00"}
{"study_id": 2947, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of Brahmyadi Churna and tablet Shilajatu (with milk as Anupana) in managing essential hypertension.", "results_summary": "The study found that 19 out of 40 patients showed marked improvement, 14 had moderate improvement, and 5 had mild improvement, with a significant reduction in blood pressure (P < 0.000). No improvement was observed in 2 individuals.", "population_specificity": "40 patients with essential hypertension.", "effective_dosage": "Not specified", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:29.621654+00:00"}
{"study_id": 2948, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy and safety of high-concentration ashwagandha root extract (HCARE) for improving sexual function in healthy women.", "results_summary": "HCARE significantly improved sexual function scores (FSFI and FSDS) and increased successful sexual encounters compared to placebo. The improvements were statistically significant across multiple domains, including arousal, lubrication, orgasm, and satisfaction.", "population_specificity": "Healthy females", "effective_dosage": "300mg twice daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:30.224900+00:00"}
{"study_id": 2939, "supplement_id": 893, "safety_score": "85", "efficacy_score": 78, "quality_score": 72, "study_goal": "The researchers aimed to evaluate the immunomodulatory and anti-inflammatory effects of the herbomineral formulation TEBEH (containing Ashwagandha) on LPS-induced cytokine expression in mouse splenocytes.", "results_summary": "TEBEH significantly inhibited pro-inflammatory cytokines (TNF-\u03b1, IL-1\u03b2, MIP-1\u03b1) while upregulating IFN-\u03b3, suggesting it promotes an anti-inflammatory environment, potentially via the NF-\u03baB pathway. The formulation was safe up to 10.53 \u03bcg/mL and showed dose-dependent immunomodulatory effects.", "population_specificity": "Mouse splenocytes (in vitro study).", "effective_dosage": "0.00001053-10.53 \u03bcg/mL (noncytotoxic range).", "study_duration": "Not specified (in vitro study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:34.224894+00:00"}
{"study_id": 2950, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the apoptotic activity of methanol extract of Ashwagandha (MEAG) in human head and neck squamous cell carcinoma (HNSCC) cells and investigate the underlying mechanisms.", "results_summary": "MEAG showed dose-dependent growth-inhibitory activity via caspase-dependent apoptosis, involving mitochondrial membrane potential loss, cytochrome c release, and Bim protein upregulation. Withaferin A (WA), a bioactive component of MEAG, induced similar apoptotic effects.", "population_specificity": "Human head and neck squamous cell carcinoma (HNSCC) cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:34.620752+00:00"}
{"study_id": 2952, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antioxidant and anti-arthritic effects of aqueous extract of Ashwagandha root (WSAq) in collagen-induced arthritic rats.", "results_summary": "WSAq demonstrated dose-dependent reductions in arthritic index, autoantibodies, and inflammatory markers, with the highest efficacy at 300 mg/kg. It also ameliorated oxidative stress by improving antioxidant parameters, showing comparable effects to methotrexate.", "population_specificity": "Collagen-induced arthritic (CIA) rats", "effective_dosage": "100, 200, and 300 mg/kg body weight, orally", "study_duration": "20 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:36.571583+00:00"}
{"study_id": 2951, "supplement_id": 893, "safety_score": "70", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Ayurvedic treatment (Ashwagandha powder and Sidh Makardhwaj) in patients with rheumatoid arthritis.", "results_summary": "The treatment showed significant improvements in tender/swollen joint counts, pain assessment, and ESR levels, with 56.4% achieving ACR20 response. However, increased urinary mercury levels were observed post-treatment.", "population_specificity": "86 patients with rheumatoid arthritis (78 completed the study) at an Ayurvedic hospital in New Delhi, India.", "effective_dosage": "5g Ashwagandha powder twice daily for 3 weeks, followed by 100mg Sidh Makardhwaj daily for 4 weeks.", "study_duration": "7 weeks total (3 weeks Ashwagandha, 4 weeks Sidh Makardhwaj).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:37.398000+00:00"}
{"study_id": 2953, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Ashwagandha's i-Extract could counteract scopolamine-induced amnesia by enhancing Arc protein function and F-actin polymerization in hippocampal neurons.", "results_summary": "The study found that Ashwagandha's i-Extract restored and enhanced F-actin polymerization and dendritic spine morphology disrupted by scopolamine or Arc antisense ODN, particularly in the CA1 hippocampal region, suggesting a role in memory recovery.", "population_specificity": "Scopolamine-induced amnesic mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:37.988227+00:00"}
{"study_id": 2954, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 65, "study_goal": "The researchers aimed to assess the efficacy of Withania somnifera (ashwagandha) in treating anxiety through a systematic review of human randomized controlled trials.", "results_summary": "Five studies met inclusion criteria, with most showing significant improvements in anxiety or stress scores compared to placebo. However, all studies had unclear or high risk of bias, and methodological heterogeneity prevented meta-analysis.", "population_specificity": "Human subjects in randomized controlled trials (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified (multiple dosage levels were compared in some studies).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:38.192974+00:00"}
{"study_id": 2949, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the effects of Ashwagandha extracts and active principles on brain pathologies, focusing on its neurodifferentiation, neuroregenerative, and neuroprotective potentials.", "results_summary": "The study highlights Ashwagandha's multidimensional effects, including differentiation of neuroblastoma and glioma cells, reversal of Alzheimer's and Parkinson's pathologies, protection against environmental neurotoxins, and memory enhancement. However, the active principles and mechanisms of action remain largely undefined.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:39.546102+00:00"}
{"study_id": 2955, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anticancer, antimigratory, anti-invasive, and anti-angiogenic effects of a combination of withanone and withaferin A derived from Ashwagandha.", "results_summary": "The study found that the combination of withanone and withaferin A selectively killed cancer cells and exhibited significant antimigratory, anti-invasive, and anti-angiogenic effects in both in vitro and in vivo assays. Bioinformatics and biochemical analyses indicated these effects were mediated through downregulation of migration-promoting proteins.", "population_specificity": "Not specified (in vitro and in vivo assays, no human subjects mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:39.673925+00:00"}
{"study_id": 2956, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Ashwagandha supercritical CO2 extract derived Withanolides (ADW) could mitigate BPA-induced mitochondrial toxicity in HepG2 cells.", "results_summary": "ADW at 100 \u03bcg/ml protected HepG2 cells from BPA-induced toxicity by suppressing mitochondrial damage, increasing ATP production, and reducing oxidative stress markers like malondialdehyde while boosting antioxidant enzyme activities.", "population_specificity": "HepG2 cells (human liver cell line)", "effective_dosage": "100 \u03bcg/ml", "study_duration": "0-72 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:41.924933+00:00"}
{"study_id": 2957, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the spermatogenic activity of Ashwagandha root extract in oligospermic patients.", "results_summary": "Ashwagandha treatment significantly increased sperm count (167%), semen volume (53%), and sperm motility (57%) compared to placebo, with minimal improvements in the placebo group. Serum hormone levels also showed greater regulation with Ashwagandha.", "population_specificity": "46 male patients with oligospermia (sperm count < 20 million/mL semen).", "effective_dosage": "675 mg/d in three doses.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.973931+00:00"}
{"study_id": 2958, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the neuroprotective effects of Ashwagandha extract against \u03b2-amyloid-induced toxicity and HIV-1Ba-L infection in human neuronal cells.", "results_summary": "Ashwagandha extract neutralized \u03b2-amyloid-induced cytotoxicity and HIV-1Ba-L infection effects in SK-N-MC cells, improving cell viability and PPAR\u03b3 levels, indicating neuroprotective potential.", "population_specificity": "Human neuronal SK-N-MC cell line", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:44.150789+00:00"}
{"study_id": 2959, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anticancer activity of Ashwagandha leaf water extract (ASH-WEX) and identify its active components.", "results_summary": "ASH-WEX showed selective cytotoxicity to cancer cells, suppressed tumors in vivo, and its active component, triethylene glycol (TEG), activated tumor suppressor proteins p53 and pRB while downregulating metastasis-related proteins MMP-3 and MMP-9 in cancer cells, with no adverse effects on normal cells.", "population_specificity": "Cancer cells (in vitro and in vivo models)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:45.727104+00:00"}
{"study_id": 2960, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Ashwagandha's alcoholic leaf extract (i-Extract) could recover scopolamine-induced amnesia in mice by modulating Arc protein expression in the hippocampus and cerebral cortex.", "results_summary": "The study found that i-Extract improved spatial learning and memory in scopolamine-treated mice, with molecular analysis showing recovery of Arc protein expression, particularly in the hippocampus. Pre-treatment with i-Extract was more effective than post-treatment.", "population_specificity": "Mice (animal study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:46.021253+00:00"}
{"study_id": 201842, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of Ashwagandha Churna supplementation combined with topical oil pooling (TOPMAC) in tinnitus suppression and hearing and cognitive function protection in elderly patients with mild to moderate presbycusis.", "results_summary": "The study is ongoing, with data analysis yet to start; results are expected by January 2025. No findings regarding Ashwagandha's effects are currently available.", "population_specificity": "Patients aged 60-75 years with mild to moderate presbycusis.", "effective_dosage": "Not specified", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:46.533654+00:00"}
{"study_id": 201844, "supplement_id": 893, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the impact of Withania somnifera (Ashwagandha) supplementation on cortisol levels in stressed humans by analyzing clinical trials.", "results_summary": "Ashwagandha supplementation decreased cortisol secretion with no significant adverse effects, but long-term effects and adrenal function impact were not evaluated.", "population_specificity": "Stressed individuals with varying degrees of stress.", "effective_dosage": "Varied across studies (specific amounts not detailed in abstract).", "study_duration": "30-112 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:47.436233+00:00"}
{"study_id": 201843, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether liposomal ashwagandha supplementation improves cognitive function, mood, and health markers in healthy young adults.", "results_summary": "Ashwagandha supplementation improved measures of memory, attention, vigilance, and executive function while reducing tension and fatigue, with several significant differences observed between the ashwagandha and placebo groups.", "population_specificity": "Healthy young men and women (average age 22.7 \u00b1 7 years, BMI 26.2 \u00b1 5).", "effective_dosage": "225 mg of liposomal ashwagandha.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:48.470465+00:00"}
{"study_id": 201845, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of ashwagandha on stress, fatigue, and sex hormones in overweight or mildly obese adults with self-reported stress and fatigue.", "results_summary": "Ashwagandha supplementation was associated with a significant reduction in stress levels, but the improvements were not significantly different from the placebo group. Secondary outcomes suggested potential anti-fatigue effects, possibly mediated by the autonomic nervous system.", "population_specificity": "Overweight or mildly obese men and women aged 40-75 years with self-reported stress and fatigue.", "effective_dosage": "200 mg of ashwagandha root extract (Witholytin\u00ae) twice daily.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:50.544610+00:00"}
{"study_id": 201846, "supplement_id": 893, "safety_score": "95", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and tolerability of a proprietary blend of Ashwagandha (WS root) and Okra (AE fruit) in relieving constipation and improving quality of life in adults.", "results_summary": "The study found that the supplement significantly reduced constipation symptoms, improved gastrointestinal function, sleep quality, and stress levels, while increasing beneficial biomarkers like serotonin and gastrin and decreasing cortisol and interleukin-6. No adverse events were reported.", "population_specificity": "Adults aged 25-60 with functional constipation (Rome-III criteria).", "effective_dosage": "300 mg or 500 mg of CL18100F4 (proprietary blend).", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:51.920756+00:00"}
{"study_id": 201848, "supplement_id": 893, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effect of Ashwagandha supplementation on anxiety and stress through a systematic review and meta-analysis of randomized clinical trials.", "results_summary": "Ashwagandha supplementation significantly reduced anxiety (SMD: -1.55, 95% CI: -2.37, -0.74; p = .005), indicating a strong effect. The study included 12 eligible papers with a total sample size of 1,002 participants.", "population_specificity": "Adults aged 25-48 years.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:52.548686+00:00"}
{"study_id": 201854, "supplement_id": 893, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical evidence for Ashwagandha's role in managing cognitive dysfunction.", "results_summary": "Ashwagandha improved cognitive performance, executive function, attention, and reaction time in most cases, with good tolerability and minimal side effects. The evidence comes from randomized, placebo-controlled, double-blind trials, though the study populations were heterogeneous.", "population_specificity": "Older adults with mild cognitive impairment and adults with schizophrenia, schizoaffective disorder, or bipolar disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:53.845189+00:00"}
{"study_id": 201850, "supplement_id": 893, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to assess the efficacy and tolerability of Ashwagandha root extract in alleviating climacteric symptoms, improving quality of life, and modulating hormonal parameters in perimenopausal women.", "results_summary": "Ashwagandha significantly reduced climacteric symptoms (measured by MRS and MENQoL scores) and improved hormonal profiles (increased estradiol, decreased FSH and LH) compared to placebo, with no significant effect on testosterone levels.", "population_specificity": "Perimenopausal women with climacteric symptoms (n=100, 91 completed).", "effective_dosage": "300 mg twice daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:54.459748+00:00"}
{"study_id": 49638, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if supramolecular assembly of salmon calcitonin with aspartame (sCT-APM) could improve bioavailability, therapeutic efficacy, and osteogenesis for osteoporosis therapy.", "results_summary": "The study found that sCT-APM nanoassemblies delayed fibrillation time, achieved sustained sCT release, showed good biocompatibility, and enhanced osteoinductive capacity compared to free sCT. In vivo results demonstrated a 2.42-fold increase in relative bioavailability and a 3.55-fold increase in therapeutic efficacy.", "population_specificity": "Not specified (in vivo study, likely animal model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:56.182789+00:00"}
{"study_id": 49639, "supplement_id": 894, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether aspartame and acesulfame K in artificially sweetened beverages adversely affected glucose control in healthy, normal-weight, overweight, and obese subjects without Type 2 diabetes.", "results_summary": "The study found no harmful effect of the artificially sweetened soft drink on glucose control, with no significant differences in fasting glucose, insulin levels, or glucose tolerance compared to mineral water consumption. Continuous glucose monitoring also showed no significant changes after 2 weeks of intake.", "population_specificity": "39 healthy subjects (BMI 18-45, age 18-75) without Type 2 diabetes.", "effective_dosage": "0.6 L/day of an artificially sweetened soft drink containing acesulfame K (950) and aspartame (951).", "study_duration": "2 weeks per intervention (crossover design with a 4-week washout).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:58.749619+00:00"}
{"study_id": 49641, "supplement_id": 894, "safety_score": "30", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the antihyperglycemic potential and hepatic safety of miracle fruit (MF) extracts versus aspartame in alloxan-induced diabetic mice.", "results_summary": "Aspartame significantly elevated alanine aminotransferase levels and caused destructive liver histopathology, while MF extracts restored hepatic architecture and improved hyperglycemia.", "population_specificity": "Alloxan-induced diabetic mice", "effective_dosage": "Not specified for aspartame (MF doses: 250 mg/kg and 500 mg/kg BW)", "study_duration": "Subchronic administration (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:59.390071+00:00"}
{"study_id": 49642, "supplement_id": 894, "safety_score": "30", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of long-term aspartame consumption on the reproductive system in male mice.", "results_summary": "The study found that aspartame consumption led to reproductive damage in male mice, including altered sperm parameters, reduced testosterone levels, increased oxidative stress, and decreased Hsp70-2 expression, particularly at higher doses (80 and 160 mg/kg).", "population_specificity": "Adult male mice", "effective_dosage": "40, 80, and 160 mg/kg (gavage)", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:00.837869+00:00"}
{"study_id": 49643, "supplement_id": 894, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to differentiate between tumors and immune cell infiltrates in Sprague-Dawley rats exposed to Aspartame and assess its potential leukaemogenic and lymphomatogenic effects.", "results_summary": "The study confirmed a statistically significant increase in total hematolymphoid tumors (HLTs), lymphomas, and leukaemias in female rats exposed to high-dose Aspartame, reinforcing its potential carcinogenic effects. The re-evaluation supported previous findings of Aspartame's leukaemogenic and lymphomatogenic impact.", "population_specificity": "Sprague-Dawley rats (female)", "effective_dosage": "High dose (specific amount not stated in abstract)", "study_duration": "Long-term (specific duration not stated in abstract)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:01.855420+00:00"}
{"study_id": 49645, "supplement_id": 894, "safety_score": "30", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to assess the biochemical, histopathological, and genotoxic effects of aspartame (ASP) alone or combined with l-carnitine (LC) on rat liver.", "results_summary": "ASP increased liver enzyme activity, disrupted lipid profiles, reduced antioxidant markers, and elevated oxidative stress and DNA damage in a dose-dependent manner. LC co-treatment mitigated these adverse effects.", "population_specificity": "Rats (animal study)", "effective_dosage": "ASP-LD (75 mg/kg), ASP-HD (150 mg/kg), LC (10 mg/kg)", "study_duration": "30 consecutive days", "interactions": "LC improved ASP-induced liver toxicity", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:03.491545+00:00"}
{"study_id": 49644, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if aspartame supplementation in starter diets accelerates small intestinal cell cycle by stimulating GLP-2 secretion and expression in pre-weaned lambs.", "results_summary": "Aspartame supplementation increased GLP-2 concentration, jejunum weight/body weight, and crypt depth, while upregulating cell cycle-related genes in the small intestine. GLP-2 indirectly promoted jejunal cell proliferation via the IGF-1 pathway.", "population_specificity": "Pre-weaned lambs (14-day-old)", "effective_dosage": "200 mg aspartame/kg starter diet", "study_duration": "35 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:03.624969+00:00"}
{"study_id": 49646, "supplement_id": 894, "safety_score": "80", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess the carcinogenic potential of aspartame, particularly in response to conflicting findings from the Ramazzini Institute.", "results_summary": "The study found no evidence of aspartame-induced tumors in any organ system, contradicting the Ramazzini Institute's findings. The only observed effects were renal pelvic mineralization and hyperplasia, deemed toxicologically insignificant.", "population_specificity": "Rats", "effective_dosage": "Up to 4 g/kg body weight/day", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:03.809721+00:00"}
{"study_id": 49637, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether a topical formulation containing CBD and aspartame (JW-100) could effectively relieve signs and symptoms of atopic dermatitis.", "results_summary": "JW-100 demonstrated statistically significant improvements in AD symptoms, with a greater reduction in ISGA scores compared to CBD alone or placebo. 50% of JW-100 patients achieved clear or almost clear skin, versus 20% and 15% in the CBD-only and placebo groups, respectively.", "population_specificity": "Patients with atopic dermatitis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:06.842706+00:00"}
{"study_id": 49648, "supplement_id": 894, "safety_score": "90", "efficacy_score": 85, "quality_score": 92, "study_goal": "The researchers aimed to assess the effect of daily aspartame ingestion for 12 weeks on glycemia, with secondary aims of evaluating its impact on appetite and body weight.", "results_summary": "The study found no significant effects of aspartame ingestion on glycemia, appetite, or body weight in healthy, lean adults, with no differences observed between the control and aspartame groups at baseline or week 12. Compliance with the intervention was high (~95%), and no adverse effects were reported.", "population_specificity": "Lean adults aged 18-60 years with a BMI of 18-25 kg/m\u00b2.", "effective_dosage": "0 mg/d (control), 350 mg/d, or 1050 mg/d of aspartame.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:08.638679+00:00"}
{"study_id": 49647, "supplement_id": 894, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of aspartame, with or without early nutritional deficiency, on anxiety-like behavior and cortical spreading depression (CSD) in developing rats.", "results_summary": "Aspartame dose-dependently reduced body weight, induced anxiety-like behavior (shorter stay in open arms in EPM), and decelerated CSD propagation speed, with stronger effects in nutritionally deficient conditions.", "population_specificity": "Newborn Wistar rats under favorable (L9) or unfavorable (L15) lactation conditions.", "effective_dosage": "75 mg/kg/d or 125 mg/kg/d administered via gavage.", "study_duration": "Postnatal days 8 to 28 (20 days).", "interactions": "Interaction with lactation conditions (nutritional deficiency) noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:08.652668+00:00"}
{"study_id": 49649, "supplement_id": 894, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the effects of chronic aspartame exposure, starting in utero, on hypothalamic and adrenal gene expression, and how developmental NMDAR antagonism modulates these effects.", "results_summary": "Aspartame exposure increased the expression of genes related to hypothalamic neurosteroidogenesis, cell stress, and inflammation, as well as adrenal GABA and glutamate receptor subunits. These effects were absent in mice with developmental NMDAR antagonism.", "population_specificity": "Adult male mice exposed to aspartame developmentally (starting in utero).", "effective_dosage": "Not specified", "study_duration": "Chronic exposure (duration not specified)", "interactions": "Developmental NMDAR antagonism (CGP 39551) modulated aspartame's effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:09.938351+00:00"}
{"study_id": 49650, "supplement_id": 894, "safety_score": "20", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate structural and ultrastructural changes in the rat's brain cerebral cortex caused by aspartame and evaluate the potential protective effects of N-acetyl-L-cysteine (NAC) and folic acid (FA).", "results_summary": "Aspartame treatment caused severe degenerative changes in nerve cells, including shrinkage, irregular shapes, and swelling, along with weak Bcl-2 immunoexpression and intense GFAP immunoreactivity. NAC and FA combined showed a protective effect against aspartame-induced damage.", "population_specificity": "Adult rats", "effective_dosage": "500 mg/kg body weight daily", "study_duration": "42 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:10.953676+00:00"}
{"study_id": 49652, "supplement_id": 894, "safety_score": "30", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate whether omega-3 fatty acids could mitigate aspartame-induced biochemical and morphological alterations in renal cells.", "results_summary": "Aspartame treatment reduced cell viability, caused DNA damage, and altered cell morphology, but these effects were reduced or reversed when omega-3 fatty acids were co-administered. Caspase-3 expression, a marker of apoptosis, increased with aspartame but decreased with omega-3 fatty acids.", "population_specificity": "In vitro renal cells (not human subjects).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:11.768244+00:00"}
{"study_id": 49653, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of early life stress and aspartame intake on metabolic and behavioral outcomes in rats.", "results_summary": "The study found that early maternal separation combined with aspartame intake led to increased blood glucose and hyperactivity in male rats but not in females, suggesting a potential risk for chronic diseases like diabetes.", "population_specificity": "Male and female rats subjected to maternal separation during breastfeeding.", "effective_dosage": "Not specified", "study_duration": "From postnatal day 26 to postnatal day 50 (24 days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:12.267311+00:00"}
{"study_id": 49651, "supplement_id": 894, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of aspartame on the medial Prefrontal Cortex (mPFC) and assess whether vitamin E could provide neuroprotective benefits against aspartame-induced damage.", "results_summary": "Aspartame consumption impaired long- and short-term memory and reduced mPFC volume, neuron count, and other structural metrics in rats. Vitamin E partially mitigated some of these effects, particularly at lower aspartame doses, but did not protect against all neurological impairments.", "population_specificity": "Rats (animal study)", "effective_dosage": "Low dose (40mg/kg/day), high dose (200mg/kg/day), and vitamin E (100mg/kg/day)", "study_duration": "8 weeks", "interactions": "Vitamin E (partial neuroprotective effect when co-administered with aspartame)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:13.226225+00:00"}
{"study_id": 49654, "supplement_id": 894, "safety_score": "40", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to consolidate evidence on whether aspartame consumption exacerbates mechanisms associated with Type II Diabetes (T2D).", "results_summary": "Aspartame may increase cortisol levels, induce oxidative stress, alter gut microbiota, and interfere with NMDA receptors, potentially leading to insulin deficiency or resistance. However, its safety for T2D remains debatable due to inconsistent data.", "population_specificity": "Individuals with Type II Diabetes (T2D).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:14.291680+00:00"}
{"study_id": 49655, "supplement_id": 894, "safety_score": "40", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether silymarin co-administration could mitigate aspartame-induced behavioral, cognitive, and cerebral changes in mice.", "results_summary": "Silymarin co-administration with aspartame reduced adverse behavioral effects (e.g., locomotion, anxiety) and improved memory, while preserving cerebral cortical integrity and modulating antioxidant activity compared to aspartame alone.", "population_specificity": "Mice", "effective_dosage": "Aspartame at 160 or 320mg/kg daily; silymarin at 25mg/kg daily", "study_duration": "21 days", "interactions": "Silymarin co-administration with aspartame", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:16.766594+00:00"}
{"study_id": 49657, "supplement_id": 894, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of aspartame at various concentrations on cell viability, morphology, ROS levels, and DNA damage in human cervical carcinoma cells.", "results_summary": "Higher concentrations of aspartame significantly altered cell viability, increased mitochondria-derived ROS, induced DNA fragmentation, and led to apoptotic and necrotic cell formation in cervical carcinoma cells.", "population_specificity": "Human cervical carcinoma cells (HeLa cells)", "effective_dosage": "1-20 mM aspartame", "study_duration": "Two time periods of exposure (specific durations not stated)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:17.585490+00:00"}
{"study_id": 49656, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the degradation and mineralization of aspartame in aqueous solution using electrochemical advanced oxidation processes (EAOPs).", "results_summary": "The study found that almost complete mineralization of aspartame was achieved using a boron-doped diamond anode at 200 mA constant current electrolysis, with the absolute rate constant for the reaction between aspartame and hydroxyl radicals determined as (5.23 \u00b1 0.02) \u00d7 10^9 M-1 s-1. The formation of carboxylic acids and inorganic ions was monitored, and the global toxicity of the treated solution was assessed using the Microtox\u00ae method.", "population_specificity": "Not applicable (in vitro study)", "effective_dosage": "Not applicable", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:17.745187+00:00"}
{"study_id": 49659, "supplement_id": 894, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess whether aspartame acts as a chemical stressor by evaluating changes in molecular mediators in rats.", "results_summary": "Aspartame administration led to increased corticosterone, lipid peroxidation, and nitric oxide levels, reduced antioxidant activity, and altered cytokine levels, suggesting immune function alteration. Methanol or formaldehyde metabolites may contribute to these changes.", "population_specificity": "Wistar Albino rats", "effective_dosage": "40 mg/kg body weight/day", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:19.687408+00:00"}
{"study_id": 49661, "supplement_id": 894, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the physiological effects of artificial sweeteners, particularly aspartame, on lipoprotein metabolism and their potential impact on antioxidant and anti-atherogenic functions of HDL.", "results_summary": "Aspartame-treated HDL showed loss of antioxidant ability, elevated atherogenic effects, and proteolytic degradation. Modified HDL exacerbated inflammatory death in zebrafish embryos, suggesting toxicity to the human circulatory system and embryonic development.", "population_specificity": "Human high-density lipoprotein (HDL) and zebrafish embryos.", "effective_dosage": "Final concentrations of 25, 50, and 100 mM aspartame.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:22.066093+00:00"}
{"study_id": 49660, "supplement_id": 894, "safety_score": "40", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to examine the impact of chronic low-dose aspartame consumption on obesity, metabolic parameters, and gut microbiota in a diet-induced obese rat model.", "results_summary": "Aspartame reduced calorie intake and weight gain but impaired glucose disposal and insulin tolerance. It also altered gut microbiota composition, increasing certain bacteria and affecting metabolic pathways linked to glucose regulation.", "population_specificity": "Male Sprague-Dawley rats on standard chow or high-fat diets.", "effective_dosage": "5-7 mg/kg/d in drinking water.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:22.246926+00:00"}
{"study_id": 49662, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the metabolic effects of a fructose-containing VLCD without aspartame versus traditional aspartame-containing VLCDs in obese subjects preparing for bariatric surgery.", "results_summary": "The study found that the fructose-containing VLCD led to significant weight reduction and improved glucose and lipid control without adverse metabolic effects, but did not directly assess aspartame's role or safety.", "population_specificity": "Obese subjects (mean BMI 39.8 kg/m\u00b2, mean age 48.8 years) preparing for bariatric surgery, including seven with type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:22.896383+00:00"}
{"study_id": 49663, "supplement_id": 894, "safety_score": "30", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of aspartame consumption and insulin treatment on CYP2E1 and CYP3A2 isozymes in the brain and liver of juvenile diabetic rats.", "results_summary": "Combined insulin and aspartame treatment significantly induced CYP2E1 in the cerebrum and cerebellum and increased CYP3A2 activity in both brain and liver, suggesting potential toxicological effects and altered drug metabolism.", "population_specificity": "Juvenile diabetic Wistar male rats (21-day-old postweaned)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Insulin", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:24.489383+00:00"}
{"study_id": 49665, "supplement_id": 894, "safety_score": "30", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the chronic effects of aspartame on ionic homeostasis and regional monoamine neurotransmitter concentrations in the brain.", "results_summary": "High-dose aspartame disrupted ionic homeostasis, induced brain apoptosis, and significantly decreased dopamine and serotonin levels in specific brain regions. It also altered tyrosine hydroxylase activity and amino acid levels.", "population_specificity": "Not specified (likely animal models, given the brain tissue analysis).", "effective_dosage": "High dose (specific amount not stated).", "study_duration": "Chronic use (specific duration not stated).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:25.805838+00:00"}
{"study_id": 49664, "supplement_id": 894, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether N-acetylcysteine could mitigate oxidative stress in rat brains caused by chronic aspartame consumption at the acceptable daily dose.", "results_summary": "Aspartame administration increased oxidative stress biomarkers in rat brains, while N-acetylcysteine treatment reduced these markers but did not fully restore all affected enzymes or glucose levels.", "population_specificity": "Rodents (rats)", "effective_dosage": "Aspartame (40 mg/kg, administered by gavage); N-acetylcysteine (150 mg/kg, intraperitoneal)", "study_duration": "Chronic administration (exact duration not specified in abstract)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:26.265028+00:00"}
{"study_id": 49666, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a rapid, simple, and stable biosensor for detecting aspartame in various sample matrices without pre-treatment.", "results_summary": "The biosensor demonstrated fast response times, high sample throughput (40 h\u207b\u00b9), and low detection limits (0.2 \u00b5M for aspartame). It was successfully applied to measure aspartame in commercial products without pre-treatment.", "population_specificity": "Not applicable (in vitro study on sample matrices/commercial products).", "effective_dosage": "Not applicable (detection method study).", "study_duration": "Not applicable (no intervention duration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:27.799077+00:00"}
{"study_id": 49658, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether aspartame could relieve atopic dermatitis (AD)-like symptoms induced by DNFB in NC/Nga mice.", "results_summary": "Aspartame at doses of 0.5 \u03bcg kg(-1) and 0.5 mg kg(-1) inhibited ear swelling, reduced inflammatory cell infiltration, suppressed cytokine expression (IL-4 and IFN-\u03b3), and lowered total serum IgE levels, demonstrating therapeutic potential for AD. Sucrose had no effect.", "population_specificity": "NC/Nga mice with DNFB-induced AD-like symptoms.", "effective_dosage": "0.5 \u03bcg kg(-1) and 0.5 mg kg(-1) (specific frequency not mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:30.200611+00:00"}
{"study_id": 49669, "supplement_id": 894, "safety_score": "65", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to investigate the genotoxic potential of aspartame and its metabolic breakdown products in mice using chromosomal aberration and sister chromatid exchange tests.", "results_summary": "Aspartame induced dose-dependent chromosomal aberrations but did not cause sister chromatid exchanges or decrease the mitotic index. Statistical analysis indicated that aspartame was not significantly genotoxic at low concentrations.", "population_specificity": "Swiss Albino male mice", "effective_dosage": "3.5, 35, 350 mg/kg body weight", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:30.495902+00:00"}
{"study_id": 49667, "supplement_id": 894, "safety_score": "30", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of repeated aspartame administration on working memory, oxidative stress, and brain monoamines in mice.", "results_summary": "Aspartame at the highest dose (5.625 mg/kg) impaired water maze performance, increased oxidative stress markers (MDA, nitric oxide), and decreased GSH and glucose levels. It also caused dose-dependent inhibition of brain serotonin, noradrenaline, and dopamine.", "population_specificity": "Mice", "effective_dosage": "0.625, 1.875, or 5.625 mg/kg administered subcutaneously once daily", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:31.852907+00:00"}
{"study_id": 49668, "supplement_id": 894, "safety_score": "40", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the angiogenic effects of Aspartame (APM) and its impact on inflammatory mediators and blood vessel formation in vitro.", "results_summary": "APM exposure induced blood vessel formation, increased ROS production in endothelial cells, and elevated levels of IL-6, VEGF-A, and their soluble receptors. APM also activated the VEGF pathway via erk1/2 and p38 phosphorylation, suggesting it acts as an angiogenic agent at low doses.", "population_specificity": "In vitro model using endothelial cells, fibroblasts, and the Angio-Kit system.", "effective_dosage": "Low doses (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:32.241997+00:00"}
{"study_id": 49670, "supplement_id": 894, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to quantify the carcinogenic risk of aspartame when exposure begins during fetal life.", "results_summary": "The study found a significant dose-related increase in malignant tumors, lymphomas/leukemias, and mammary cancer in rats exposed to aspartame, particularly at higher doses (2,000 ppm). The results reinforced aspartame's multipotential carcinogenicity, especially when exposure starts prenatally.", "population_specificity": "Sprague-Dawley rats (male and female) exposed from the 12th day of fetal life until natural death.", "effective_dosage": "2,000 ppm, 400 ppm, or 0 ppm administered with feed.", "study_duration": "From the 12th day of fetal life until natural death.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:34.490666+00:00"}
{"study_id": 49672, "supplement_id": 894, "safety_score": "40", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether chronic aspartame consumption affects cytochrome P450 enzyme activity in rat brain and liver.", "results_summary": "The study found that aspartame increased cytochrome P450 enzyme activity in rat brain (cerebrum and cerebellum) but not in the liver, with varying fold changes across different enzymes. The effects were dose-dependent, with the 75 mg/kg dose showing consistent increases.", "population_specificity": "Wistar rats", "effective_dosage": "75 and 125 mg/kg body weight daily", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:35.408370+00:00"}
{"study_id": 49671, "supplement_id": 894, "safety_score": "20", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the long-term carcinogenic potential of Aspartame in rats under controlled experimental conditions.", "results_summary": "The study found that Aspartame increased the incidence of malignant tumors, lymphomas-leukemias, transitional cell carcinomas, and malignant schwannomas in rats, with dose-dependent trends and statistical significance. The results suggest Aspartame is a multipotential carcinogenic agent under the tested conditions.", "population_specificity": "Male and female Sprague-Dawley rats (100-150/sex/group), 8 weeks old at the start of the experiment.", "effective_dosage": "100,000, 50,000, 10,000, 2,000, 400, 80, or 0 ppm administered in feed.", "study_duration": "Treatment lasted until spontaneous death of the animals.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:35.997321+00:00"}
{"study_id": 49673, "supplement_id": 894, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether aspartame has carcinogenic effects in rats under long-term exposure.", "results_summary": "The study found that aspartame increased the incidence of malignant tumors, lymphomas, leukemias, transitional cell carcinomas, and malignant schwannomas in rats, with dose-dependent trends and statistical significance. The results suggest aspartame is a multipotential carcinogenic agent even at doses below the current acceptable daily intake.", "population_specificity": "Sprague-Dawley rats (100-150/sex/group), 8 weeks old at study start.", "effective_dosage": "100,000, 50,000, 10,000, 2,000, 400, 80, or 0 ppm administered with feed.", "study_duration": "Treatment lasted until natural death.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:37.267532+00:00"}
{"study_id": 49674, "supplement_id": 894, "safety_score": "30", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to investigate the genotoxic effects of aspartame using various tests, including chromosome aberration, sister chromatid exchange, micronucleus, and Ames/Salmonella/microsome tests.", "results_summary": "Aspartame induced chromosome aberrations dose-dependently at all concentrations and treatment periods, decreased mitotic index dose-dependently, and induced micronuclei at the highest concentrations. It did not induce sister chromatid exchanges or show mutagenic effects in Salmonella typhimurium strains.", "population_specificity": "Human lymphocytes", "effective_dosage": "500, 1000, and 2000 \u00b5g/ml", "study_duration": "24 and 48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:39.024857+00:00"}
{"study_id": 49677, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the antimutagenic effects of aspartame in combination with beta-carotene on reducing chromosome aberrations in mice exposed to clastogenic agents.", "results_summary": "The combination of aspartame and beta-carotene reduced clastogenic effects of dioxidine and cyclophosphamide in mice, showing a more potent and universal antimutagenic effect than either constituent alone. Both single and 5-day treatments demonstrated efficacy.", "population_specificity": "C57Bl/6 mice", "effective_dosage": "Aspartame (0.4 and 4 mg/kg), beta-carotene (0.15-15 mg/kg)", "study_duration": "Single and 5-day treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:40.917121+00:00"}
{"study_id": 49676, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether chronic aspartame exposure has analgesic and anti-inflammatory effects similar to aspirin in a carrageenan-induced monoarthritis model.", "results_summary": "Aspartame at 50 mg/kg attenuated mechanical allodynia but did not reduce inflammation, increase motor activity, or affect thermal allodynia. Aspirin reduced mechanical hyperalgesia and inflammation but did not reverse thermal hyperalgesia or restore motor activity to control levels.", "population_specificity": "Male Sprague-Dawley rats with carrageenan-induced monoarthritis.", "effective_dosage": "25, 50, and 100 mg/kg aspartame for six days; 150 mg/kg aspirin on the sixth day.", "study_duration": "Six days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:41.107259+00:00"}
{"study_id": 49680, "supplement_id": 894, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Aspartame could prevent the accumulation of Ochratoxin A (OTA) in the brain and mitigate its neurotoxic effects in rats.", "results_summary": "Aspartame significantly reduced OTA accumulation in the brain and prevented OTA-induced changes in tyrosine and phenylalanine levels. It also reduced histological signs of neurotoxicity, such as necrotic cells with pyknotic nuclei.", "population_specificity": "Young adult rats", "effective_dosage": "25 mg/kg every 48 hours", "study_duration": "1 to 6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:43.286682+00:00"}
{"study_id": 49678, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the thermal stability of solid-state aspartame hemihydrate and identify impurity formation during heating.", "results_summary": "The study found that solid-state aspartame undergoes water evaporation, dehydration, and cyclization at specific temperatures (50, 110, and 153\u00b0C), leading to the formation of the impurity 3-carboxymethyl-6-benzyl-2,5-diketopiperazine (DKP). The novel FT-IR/DSC microscopic system effectively detected these thermal-dependent changes in a single step.", "population_specificity": "Not applicable (in vitro study on solid-state aspartame)", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:43.492182+00:00"}
{"study_id": 49679, "supplement_id": 894, "safety_score": "90", "efficacy_score": 85, "quality_score": 92, "study_goal": "The researchers sought to determine whether aspartame disrupts cognitive, neurophysiologic, or behavioral functioning in healthy individuals.", "results_summary": "The study found no significant differences in neuropsychologic, neurophysiologic, or behavioral functioning between aspartame and placebo groups, even at high doses. Plasma phenylalanine levels increased during aspartame treatment, but no adverse effects were observed.", "population_specificity": "48 healthy young adults.", "effective_dosage": "High-dose (45 mg/kg body weight/day) and low-dose (15 mg/kg body weight/day).", "study_duration": "20 days per treatment period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:43.628296+00:00"}
{"study_id": 49681, "supplement_id": 894, "safety_score": "20", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate the metabolic fate of aspartame in rats, focusing on the formation and binding of formaldehyde adducts to tissue components.", "results_summary": "The study found that aspartame-derived radioactivity was predominantly bound to proteins and nucleic acids, with significant retention in tissues, particularly the liver. Chronic aspartame administration led to cumulative formaldehyde adduct formation, suggesting potential long-term hazards.", "population_specificity": "Adult male rats, including a subset with cirrhosis.", "effective_dosage": "10 mg/kg (acute), 200 mg/kg (chronic, for 10 days).", "study_duration": "Acute (up to 6 hours), chronic (10 days).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:45.855430+00:00"}
{"study_id": 49682, "supplement_id": 894, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if aspartame exhibits biological activity, including pain relief, antithrombotic effects, and antipyretic properties.", "results_summary": "Aspartame demonstrated pain relief in osteoarthritis patients, mild antithrombotic effects in humans, and reduced fever in rats. Results were statistically significant (p < 0.001 for pain relief, p < 0.01 for other effects).", "population_specificity": "Human subjects (osteoarthritis patients, normal volunteers) and Sprague-Dawley rats.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:47.712185+00:00"}
{"study_id": 49683, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether adding aspartame to a weight-control program improves weight loss and long-term weight maintenance in obese women.", "results_summary": "The study found that aspartame intake was positively correlated with greater weight loss during active weight loss and significantly less weight regain during maintenance and follow-up compared to the no-aspartame group. Exercise and self-reported eating control also positively influenced weight loss outcomes.", "population_specificity": "163 obese women", "effective_dosage": "Not specified", "study_duration": "19-week weight-reduction program (16 weeks active weight loss), 1-year maintenance, and 2-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:48.878152+00:00"}
{"study_id": 49687, "supplement_id": 894, "safety_score": "90", "efficacy_score": 85, "quality_score": 95, "study_goal": "The researchers aimed to evaluate the effects of aspartame on cognitive function, EEGs, and biochemical parameters in heterozygotes for phenylketonuria (PKUH).", "results_summary": "The study found that aspartame had no effect on cognitive function, EEGs, or urinary organic acids. Plasma phenylalanine increased within the normal range for PKUH at the higher dose but did not result in adverse effects.", "population_specificity": "48 adult heterozygotes for phenylketonuria (PKUH) (21 men, 27 women).", "effective_dosage": "15 or 45 mg/kg/day.", "study_duration": "12 weeks per treatment (crossover study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:51.904304+00:00"}
{"study_id": 49685, "supplement_id": 894, "safety_score": "70", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether aspartame ingestion is associated with headaches in individuals who self-reported headaches after aspartame use.", "results_summary": "The study found that subjects reported headaches on 33% of days during aspartame treatment compared to 24% on placebo (p = 0.04), with a subset of individuals (\"very sure\" of aspartame-triggered headaches) showing larger treatment differences. No significant differences were observed in headache length, intensity, or associated side effects.", "population_specificity": "Volunteers with self-identified headaches after aspartame use (n=32, with 18 completing the full protocol).", "effective_dosage": "Approximately 30 mg/kg/day.", "study_duration": "Each experimental period was 7 days long.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:52.592608+00:00"}
{"study_id": 49686, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of phenylalanine and aspartame on food intake in human volunteers, particularly focusing on potential appetite suppression.", "results_summary": "The study initially reported no effects on food intake from high doses of phenylalanine and aspartame, but a reanalysis of the raw data suggested dose-related suppression of food intake by phenylalanine and possible anorexic effects of aspartame and alanine. These findings indicate that amino acids and small peptides may influence appetite and warrant further investigation.", "population_specificity": "Human volunteers", "effective_dosage": "Up to 10.08 g of phenylalanine and aspartame in capsules", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:53.349647+00:00"}
{"study_id": 49688, "supplement_id": 894, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether aspartame provokes seizures in children with well-documented seizure disorders.", "results_summary": "The study found no significant differences between aspartame and placebo in EEG results, behavioral ratings, or biochemical measures, except for expected increases in phenylalanine and tyrosine after aspartame. Aspartame did not provoke seizures in this vulnerable group.", "population_specificity": "10 children (5 boys, 5 girls, ages 5-13 years) with well-documented seizures (generalized convulsions, absence episodes, or complex partial seizures).", "effective_dosage": "Single morning dose of 34 mg/kg.", "study_duration": "2 weeks per arm (aspartame and placebo).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:55.756938+00:00"}
{"study_id": 49689, "supplement_id": 894, "safety_score": "90", "efficacy_score": 85, "quality_score": 92, "study_goal": "To determine the effects of large doses of aspartame on behavior, cognition, and monoamine metabolism in children with attention deficit disorder.", "results_summary": "The study found no clinically significant differences between aspartame and placebo in behavioral, cognitive, or biochemical measures, except for expected increases in plasma phenylalanine and tyrosine. Aspartame at more than 10 times usual consumption had no effect on cognitive and behavioral status or monoamine excretion rates.", "population_specificity": "Children with attention deficit disorder (unmedicated, meeting DSM-3 criteria).", "effective_dosage": "Single morning dose of 34 mg/kg.", "study_duration": "Alternate 2-week periods.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:56.606727+00:00"}
{"study_id": 49690, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether the appetite reduction observed after consuming aspartame-sweetened drinks was due to the drink volume or the aspartame content.", "results_summary": "The study found that appetite reduction was due to drink volume, not aspartame content. Consuming aspartame-sweetened carbonated mineral water increased subjective appetite, while encapsulated aspartame had no effect.", "population_specificity": "Eighteen normal-weight young adult males.", "effective_dosage": "170 mg and 340 mg aspartame in varying drink volumes.", "study_duration": "One week per treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:57.516100+00:00"}
{"study_id": 49675, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of aspartame on pain modulation and its mechanism of action, particularly in combination with calcium channel blockers and nitric oxide synthase inhibitors.", "results_summary": "Aspartame (0.16% w/v) significantly induced antinociception in both phases of the formalin test, and its effects were potentiated by verapamil and L-NAME, suggesting a role in pain modulation via NMDA receptor activation.", "population_specificity": "Mice", "effective_dosage": "0.16% w/v aspartame", "study_duration": "12 days", "interactions": "Potentiation of antinociception with verapamil (5 mg/kg) and L-NAME (10 mg/kg)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:57.723528+00:00"}
{"study_id": 49684, "supplement_id": 894, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether aspartame, at an acute dosage of 50 mg/kg, could provoke seizures in individuals who reported seizures allegedly related to aspartame consumption.", "results_summary": "The study found no clinical seizures or adverse effects after aspartame ingestion, despite increased plasma phenylalanine levels. Results suggest aspartame is no more likely than placebo to cause seizures in this population.", "population_specificity": "18 individuals (16 adults and 2 children) who reported seizures allegedly linked to aspartame consumption.", "effective_dosage": "50 mg/kg, administered in divided doses at 0800, 1000, and 1200 h on study days 2 and 4.", "study_duration": "5 days (intervention administered on days 2 and 4).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:58.407621+00:00"}
{"study_id": 49691, "supplement_id": 894, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether aspartame affects complex mental operations, particularly aviation-relevant cognitive tasks, compared to placebo and alcohol.", "results_summary": "The study found no detectable performance decrements associated with aspartame, unlike the ethanol condition, which showed impairments in psychomotor and spatial abilities. Results did not support anecdotal concerns about aspartame's negative cognitive effects.", "population_specificity": "Thirteen pilots tested under controlled conditions.", "effective_dosage": "50 mg/kg body weight.", "study_duration": "Five testing sessions (pretest, posttest, and three treatment sessions).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:59.771690+00:00"}
{"study_id": 49692, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether aspartame-sweetened beverages affect subjective hunger, energy intake, and macronutrient selection at a lunch-time meal.", "results_summary": "The study found no effects of aspartame-sweetened beverages on energy intake, macronutrient selection, or food choice, though restrained eaters consumed more than nonrestrained eaters. Consumption of two soft drinks (560 ml, 320 mg aspartame) temporarily reduced subjective hunger compared to one soft drink or water.", "population_specificity": "20 normal-weight young adult males, classified as restrained or nonrestrained eaters.", "effective_dosage": "160 mg (280 ml) or 320 mg (560 ml) aspartame, administered once.", "study_duration": "Single administration, effects measured over 3 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:01.696910+00:00"}
{"study_id": 49693, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether phenylalanine, a breakdown product of aspartame, accounts for aspartame's anorexic effect by suppressing food intake in humans.", "results_summary": "Capsulated aspartame (400 mg) reduced food intake by 15% in a lunchtime test meal, but neither phenylalanine nor aspartic acid alone had this effect. The study suggests aspartame may intensify satiety effects of ingested food, though the mechanism remains unclear.", "population_specificity": "Human volunteers", "effective_dosage": "400 mg aspartame, 200 mg phenylalanine, 200 mg aspartic acid", "study_duration": "Single administration with meal test 1 hour later", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:01.950488+00:00"}
{"study_id": 49695, "supplement_id": 894, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to compare the bioavailability of aspartame's constituent amino acids (aspartate and phenylalanine) when administered in capsules versus solution.", "results_summary": "The study found that aspartame in capsules resulted in a slower absorption rate of phenylalanine compared to solution, with a smaller peak plasma concentration and longer time to peak, but no significant difference in overall absorption extent. The maximum plasma Phe/LNAA ratio was also smaller with capsules, while other large neutral amino acids remained unaffected.", "population_specificity": "20 healthy subjects", "effective_dosage": "Single 20 mg/kg dose", "study_duration": "Single administration (crossover design)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:04.285314+00:00"}
{"study_id": 49696, "supplement_id": 894, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of aspartame on learning, behavior, and mood in children compared to other sweeteners.", "results_summary": "The study found no significant effects of aspartame on associative learning, arithmetic calculation, activity level, social interaction, or mood in experiment 1. In experiment 2, minor and gross motor behaviors were less frequent after sucrose consumption compared to aspartame.", "population_specificity": "Healthy 9- to 10-year-old children.", "effective_dosage": "34 mg/kg (experiment 1), 9.7 mg/kg (experiment 2).", "study_duration": "Short-term (single administration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:05.746217+00:00"}
{"study_id": 49694, "supplement_id": 894, "safety_score": "80", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to determine whether aspartame increases susceptibility to metrazol-induced convulsions and its effects on plasma and brain levels of phenylalanine and tyrosine in mice and guinea-pigs.", "results_summary": "Aspartame did not potentiate metrazol-induced convulsions in mice or guinea-pigs, even at high doses (up to 2 g/kg). It significantly increased phenylalanine and tyrosine levels in plasma and brain, but only at higher doses, with no observed changes in monoamine or metabolite levels in brain striata.", "population_specificity": "CD1 and DBA/2J mice, guinea-pigs, and rats (as positive controls).", "effective_dosage": "0.5, 0.75, 1, and 2 g/kg body weight (administered orally to mice and intraperitoneally to guinea-pigs).", "study_duration": "Acute administration (single dose).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:05.944011+00:00"}
{"study_id": 49697, "supplement_id": 894, "safety_score": "70", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to study the effects of aspartame on plasma and brain phenylalanine and tyrosine levels, as well as monoamine concentrations in the corpora striatum of male rats.", "results_summary": "Aspartame administration led to increased phenylalanine and tyrosine levels in plasma and brain, peaking at 60 minutes. No significant changes in monoamine levels were observed in the corpora striatum up to 5 hours after dosing.", "population_specificity": "Male rats", "effective_dosage": "250 mg/kg and 1000 mg/kg body weight (single oral dose)", "study_duration": "Up to 5 hours post-dosing", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:05.994501+00:00"}
{"study_id": 49698, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether aspartame affects hunger, fullness, desire to eat, or food intake in children compared to other sweeteners (sodium cyclamate and sucrose).", "results_summary": "The study found no significant effect of aspartame on subjective feelings of appetite or lunch-time food intake in children, whether consumed alone or with carbohydrates, compared to sodium cyclamate or sucrose.", "population_specificity": "20 healthy 9-10-year-old children per experiment.", "effective_dosage": "Experiment 1: 34 mg/kg aspartame; Experiment 2: 9.7 mg/kg aspartame.", "study_duration": "Single-day intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:07.282265+00:00"}
{"study_id": 49699, "supplement_id": 894, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether high doses of aspartame administered during late gestation in mice affected developmental parameters, particularly the visual system.", "results_summary": "The study found no adverse effects on maternal health, reproductive indices, or offspring development, including visual system development, even at extremely high doses of aspartame.", "population_specificity": "CF-1 mice (offspring of maternal administration during late gestation)", "effective_dosage": "500, 1000, 2000, and 4000 mg/kg body weight by oral gavage", "study_duration": "Days 15 through 18 of gestation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:08.218116+00:00"}
{"study_id": 49700, "supplement_id": 894, "safety_score": "70", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether gestational exposure to aspartame affects odor-associative learning in newborn guinea pigs.", "results_summary": "The study found no significant effects of aspartame on maternal weight gain, litter size, or birth weight, but it disrupted odor-associative learning in 15-day-old guinea pigs exposed to LiCl.", "population_specificity": "Pregnant guinea pigs and their offspring.", "effective_dosage": "500 mg/kg administered in sesame oil by gavage.", "study_duration": "From conception to parturition.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:09.123862+00:00"}
{"study_id": 49701, "supplement_id": 894, "safety_score": "80", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to determine whether large doses of aspartame or L-phenylalanine affect seizure susceptibility and severity in a primate model of epilepsy.", "results_summary": "The study found no changes in epileptic responses 1-5 hours after administering aspartame or L-phenylalanine, indicating that acute increases in plasma phenylalanine concentration are neither pro- nor anticonvulsant.", "population_specificity": "Baboons (Papio papio) from Senegal with photosensitive epileptic responses similar to primary generalized epilepsy in humans.", "effective_dosage": "Aspartame doses of 300 or 1000 mg/kg, administered orally.", "study_duration": "Acute administration (effects assessed 1-5 hours post-dose).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:10.263564+00:00"}
{"study_id": 49702, "supplement_id": 894, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether aspartame affects seizure threshold or strength in rats using an electrical kindling model of epilepsy.", "results_summary": "The study found no evidence that aspartame administration (25-2000 mg/kg) affected afterdischarge threshold or seizure strength in rats, even when serum and brain levels of neutral amino acids were elevated. Previous studies on aspartame's potential to induce seizures have yielded mixed results.", "population_specificity": "Rats (amygdala and hippocampal kindled seizure model)", "effective_dosage": "25-2000 mg/kg (administered by gavage)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:12.064686+00:00"}
{"study_id": 49704, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether adding aspartame-sweetened foods and beverages to a low-fat, hypocaloric diet improves compliance and enhances weight loss.", "results_summary": "Males achieved clinically significant weight loss in both groups, while females lost more weight in the aspartame-supplemented group (16.5 lb vs. 12.8 lb). Both groups showed improvements in sleep, energy, physical activity, and well-being.", "population_specificity": "59 obese men and women (130-225% of ideal body weight).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:13.745552+00:00"}
{"study_id": 49705, "supplement_id": 894, "safety_score": "85", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether aspartame consumption was more likely to cause headaches compared to a placebo in individuals who reported headaches after consuming aspartame-containing products.", "results_summary": "The study found no significant difference in headache incidence between aspartame (35%) and placebo (45%). No serious adverse effects or changes in vital signs or plasma concentrations were observed, though subjects with headaches had lower plasma norepinephrine and epinephrine levels.", "population_specificity": "40 subjects who reported repeated headaches after aspartame consumption, mostly well-educated, overweight, and with a personal or family history of allergic reactions.", "effective_dosage": "30 mg of aspartame per kilogram of body weight.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:14.638699+00:00"}
{"study_id": 49703, "supplement_id": 894, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether aspartame affects plasma and brain amino acid concentrations in humans and rats under different dietary conditions.", "results_summary": "Aspartame had no significant effect on plasma amino acid concentrations in humans under realistic consumption conditions. In rats, acute dosing altered plasma amino acids, but subacute treatment showed no significant changes in plasma, brain amino acids, or brain monoamines.", "population_specificity": "Fasted human volunteers (n=30) and rats.", "effective_dosage": "0.83 and 8.3 mg aspartame/kg body weight in humans; included in diet for rats.", "study_duration": "Acute (single dose) and subacute (14 days) in rats.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:15.995294+00:00"}
{"study_id": 49706, "supplement_id": 894, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether phenylalanine and aspartame affect short-term energy intake, macronutrient selection, and subjective feelings of hunger, mood, and arousal in normal-weight adult males.", "results_summary": "The study found that neither phenylalanine nor aspartame altered energy intake or macronutrient selection, nor did they affect subjective feelings of hunger, mood, or arousal, despite increased plasma phenylalanine levels. No treatment effects or interactions were observed for any variable.", "population_specificity": "Normal-weight adult males", "effective_dosage": "5.04 g and 10.08 g aspartame", "study_duration": "Short-term (lunch began 60 to 105 minutes after consumption)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:16.149272+00:00"}
{"study_id": 49707, "supplement_id": 894, "safety_score": "30", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of aspartame on neurotransmitter concentrations in various brain regions of mice and assess potential neurologic and behavioral disturbances.", "results_summary": "Aspartame increased norepinephrine concentrations in the hypothalamus, medulla oblongata, and corpus striatum, as well as dopamine and its metabolites in various regions, while serotonin and its metabolite remained unaffected. These changes suggest aspartame may influence brain catecholamine levels, potentially contributing to reported clinical and behavioral effects.", "population_specificity": "Unfasted male CD-1 mice", "effective_dosage": "13, 130, or 650 mg/kg ASM in corn oil (single dose)", "study_duration": "Single dose, effects measured 3 hours post-administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:17.903827+00:00"}
{"study_id": 49708, "supplement_id": 894, "safety_score": "80", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to measure serum methanol concentrations in rats and humans after oral aspartame administration to assess its metabolic effects.", "results_summary": "Aspartame administration caused a temporary rise in serum methanol in both rats and humans, with peak levels occurring within 1 hour in rats and 45 minutes in humans, returning to baseline within 4 hours and 2 hours, respectively. The peak methanol levels remained within the range of individual basal levels.", "population_specificity": "Rats and four male adult volunteers.", "effective_dosage": "Rats: 34 mg/kg (single dose); Humans: 500 mg (6-8.7 mg/kg, single dose).", "study_duration": "Single administration with follow-up measurements up to 4 hours in rats and 2 hours in humans.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:18.200931+00:00"}
{"study_id": 201860, "supplement_id": 894, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers were comparing the effects of carbohydrate ingestion versus a placebo (saccharin and aspartame solution) on force output and time to exhaustion during static muscle contractions.", "results_summary": "The study found no significant effects of the aspartame-containing placebo on force output or time to exhaustion compared to carbohydrate ingestion, which significantly improved both metrics. The placebo group showed lower performance outcomes.", "population_specificity": "Six trained male subjects", "effective_dosage": "Equal volume of a solution made of saccharin and aspartame (exact dosage not specified)", "study_duration": "Until failure occurred during the exercise protocol (PL group mean = 16.0 \u00b1 8.1 minutes)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:19.023202+00:00"}
{"study_id": 1884, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to characterize immune cell interactions and dysregulation in anti-NMDARE using single-cell multi-omics sequencing technologies.", "results_summary": "The study revealed significant B cell clonal expansion, particularly in plasma cells, driven by antigen recognition, and identified IFN-I and TLR2 pathway activation as potential contributors to immune dysregulation.", "population_specificity": "Patients in the acute phase of anti-NMDARE and healthy controls.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:19.124448+00:00"}
{"study_id": 1885, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "To assess whether D-serine supplementation can mitigate synaptic plasticity impairments caused by anti-NMDAR antibodies in a mouse model of anti-NMDAR encephalitis.", "results_summary": "D-serine improved hippocampal long-term potentiation impairments caused by anti-NMDAR antibodies but did not reverse decreased NMDAR expression. No significant behavioral differences were observed between treated and control mice.", "population_specificity": "C57BL/6 mice injected with anti-NMDAR antibodies from human patients.", "effective_dosage": "500 mg/kg intraperitoneally for three consecutive days.", "study_duration": "Three days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:22.059555+00:00"}
{"study_id": 1886, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify predictors of macrophage activation syndrome (MAS) in childhood-onset systemic lupus erythematosus (cSLE), including the role of elevated aspartate aminotransferase (AST) levels.", "results_summary": "Elevated AST levels (\u226561 U/L) were identified as a predictor of MAS occurrence in cSLE patients, alongside other markers like ferritin and LDH. The study found no recurrence of MAS in patients during an 18-month follow-up.", "population_specificity": "157 patients diagnosed with childhood-onset systemic lupus erythematosus (cSLE), with or without MAS.", "effective_dosage": "Not specified", "study_duration": "Mean follow-up of 18 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:23.364526+00:00"}
{"study_id": 1888, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to report a case of anti-NMDA receptor encephalitis, highlighting its presentation, diagnosis, and treatment outcomes.", "results_summary": "The study found that a 24-year-old female with anti-NMDA receptor encephalitis showed significant improvement after treatment with high-dose corticosteroids and intravenous immunoglobulin, with follow-up MRI confirming reduced lesion size. The case underscores the importance of early diagnosis and awareness of atypical presentations.", "population_specificity": "24-year-old female with no significant medical history.", "effective_dosage": "High-dose corticosteroids and intravenous immunoglobulin (specific amounts not provided).", "study_duration": "Three weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:24.283537+00:00"}
{"study_id": 1887, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the impact of insulin and magnesium supplements on the expression of GABAergic and NMDA receptors, including N-methyl-D-aspartate (NMDA), in the stomach of type 2 diabetic rats.", "results_summary": "The study found that magnesium and insulin improved NOS-1 expression and restored GABA-A and GABA-B receptor levels in diabetic rats, with magnesium showing a stronger effect. Insulin also improved GABA-A receptor expression, but NMDA receptor levels remained unchanged.", "population_specificity": "Male Wistar rats with type 2 diabetes induced by a high-fat diet and low-dose streptozotocin.", "effective_dosage": "Not specified", "study_duration": "Three months (high-fat diet) + treatment duration not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:24.962541+00:00"}
{"study_id": 1890, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine how serum levels of D- and L-aspartate vary across different stages of psychosis progression and their potential as biomarkers.", "results_summary": "The study found that increased D-aspartate/total aspartate ratios were associated with early stages of psychosis, while elevated L-aspartate levels were linked to chronic schizophrenia. These changes suggest dysregulation in aspartate metabolism during psychosis progression.", "population_specificity": "Individuals diagnosed with At-Risk Mental State (ARMS), First Episode of Psychosis (FEP), full-blown schizophrenia, and Healthy Donors (HD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:26.301055+00:00"}
{"study_id": 1892, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential and risks of memantine as an adjunct therapy for N-methyl-D-aspartate receptor encephalitis (NMDARE), focusing on its dual effects on symptom reduction and neuronal communication impairment.", "results_summary": "Memantine showed variable effectiveness in treating NMDARE, with potential benefits from blocking excessive NMDA receptor antibody binding but risks from reducing extracellular NMDAR availability, impairing neuronal communication. Comprehensive analyses remain scarce, highlighting the need for further investigation.", "population_specificity": "Patients with N-methyl-D-aspartate receptor encephalitis (NMDARE).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:26.852231+00:00"}
{"study_id": 1889, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to describe a case of anti-NMDAR encephalitis and its management, highlighting diagnostic challenges and treatment strategies.", "results_summary": "The study reported a 19-year-old female with anti-NMDAR encephalitis presenting with catatonia and other neurological symptoms, diagnosed using clinical criteria and antibody testing. Treatment with methylprednisolone and plasma exchanges was initiated, emphasizing the need for refined therapeutic approaches.", "population_specificity": "19-year-old female with anti-NMDAR encephalitis and an ovarian teratoma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:26.911328+00:00"}
{"study_id": 1893, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to examine the treatment outcomes of anti-NMDAR encephalitis associated with small cell lung cancer, focusing on the effectiveness of immunotherapy.", "results_summary": "The study found that immunotherapy alone was insufficient for treating anti-NMDAR encephalitis caused by small cell lung cancer, as the patient showed no improvement in consciousness and ultimately died. Combined immunotherapy and cancer therapy is suggested for better outcomes.", "population_specificity": "A 66-year-old man with anti-NMDAR encephalitis and small cell lung cancer.", "effective_dosage": "Not specified", "study_duration": "101 days (until death)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:26.966525+00:00"}
{"study_id": 1894, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to describe an unusual presentation of paraneoplastic neurological syndrome (PNS) with dual antibody positivity in a patient diagnosed with lung cancer.", "results_summary": "The study reported an unusual case of PNS with dual antibody positivity in a lung cancer patient, highlighting the variability in PNS presentations and the importance of updated diagnostic criteria.", "population_specificity": "A single patient diagnosed with lung cancer presenting with PNS.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:29.659406+00:00"}
{"study_id": 1895, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between anti-N-methyl-D-aspartate antibodies and paraneoplastic encephalitis in a patient with an ovarian teratoma.", "results_summary": "The study found that the presence of anti-N-methyl-D-aspartate antibodies in cerebrospinal fluid was linked to paraneoplastic encephalitis, and surgical removal of the ovarian teratoma led to resolution of symptoms.", "population_specificity": "22-year-old female with refractory insomnia, disorganized behavior, and visual hallucinations.", "effective_dosage": "Not specified", "study_duration": "Treatment initiated upon admission; surgery performed on day 25.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:31.231490+00:00"}
{"study_id": 1896, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers were investigating whether human norovirus (NoV) infection could be a trigger for anti-NMDAR encephalitis.", "results_summary": "The study reported a case of a 15-month-old girl with NoV infection who developed anti-NMDAR encephalitis, suggesting a possible link between NoV infection and this neurological condition. Treatment with intravenous immunoglobulin and glucocorticoid led to almost complete recovery.", "population_specificity": "15-month-old girl with NoV infection and neurological symptoms.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:31.564712+00:00"}
{"study_id": 1897, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether fluoroquinolone-based antibiotics (norfloxacin, ciprofloxacin, and sparfloxacin) could inhibit plasmepsin II (an aspartate protease) and serve as potential antimalarial drugs.", "results_summary": "Norfloxacin and ciprofloxacin effectively inhibited plasmepsin II activity, while sparfloxacin did not due to structural hindrance. The findings suggest these fluoroquinolones could be repurposed as antimalarial inhibitors targeting aspartate proteases.", "population_specificity": "In vitro study (enzyme kinetics and molecular docking, no human or animal subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:33.988251+00:00"}
{"study_id": 1898, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to document a rare case of relapsing anti-N-methyl-D-aspartate receptor encephalitis occurring 8 years after initial diagnosis and evaluate treatment outcomes.", "results_summary": "The study found that immunotherapy and plasmapheresis led to complete recovery in a 16-year-old female with relapsing anti-N-methyl-D-aspartate receptor encephalitis, highlighting the rarity of late relapse beyond 5 years.", "population_specificity": "16-year-old Iranian female with relapsing anti-N-methyl-D-aspartate receptor encephalitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:34.087461+00:00"}
{"study_id": 1901, "supplement_id": 895, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of zinc aspartate and zinc citrate on disease severity and markers of rheumatoid arthritis in Wistar rats, as well as their antimicrobial activity against E. coli.", "results_summary": "Zinc aspartate and zinc citrate reduced clinical characteristics of rheumatoid arthritis in rats and exhibited antimicrobial effects against E. coli, with no adverse effects observed at the tested dose.", "population_specificity": "Male Wistar rats with collagen-induced arthritis.", "effective_dosage": "Equivalent to 50 mg/day of elemental zinc.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:34.955427+00:00"}
{"study_id": 1902, "supplement_id": 895, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify whether L-aspartate could regulate energy expenditure and serve as a potential therapeutic for obesity prevention and treatment.", "results_summary": "L-aspartate was found to reduce body weight by 14.5% in HFC diet mice and 8.5% in obese mice, improve metabolic syndrome, enhance energy expenditure, and suppress adipogenesis via AMPK activation.", "population_specificity": "C57BL/6 mice fed a high-fat, high-cholesterol diet and 3T3-L1 preadipocytes; human BMI correlation was also evaluated.", "effective_dosage": "200 mg/kg L-aspartate orally administered.", "study_duration": "6-7 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:35.618041+00:00"}
{"study_id": 1900, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine how Indole-3-acetyl-aspartate (IAA-Asp) modulates plant response to osmotic shock and oxidative stress, focusing on glutathione metabolism and protein S-glutathionylation.", "results_summary": "IAA-Asp independently modulated redox status in pea seedlings, increasing glutathione reductase (GR) activity and GSH/GSSG ratio in short-term treatments but decreasing them in longer exposures. It also influenced protein S-glutathionylation, particularly affecting HSP70 and lipoxygenase under stress conditions.", "population_specificity": "Pea (Pisum sativum L.) seedlings", "effective_dosage": "Not specified", "study_duration": "3 hours and 48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:35.693720+00:00"}
{"study_id": 1903, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to highlight the importance of considering anti-NMDAR encephalitis in young female patients with neuropsychiatric symptoms, particularly those with ovarian teratomas.", "results_summary": "The study detailed a case of anti-NMDAR encephalitis secondary to an ovarian teratoma, emphasizing diagnostic challenges and the need for multidisciplinary management. Treatment included immunotherapy and surgical removal of the teratoma, leading to improved outcomes.", "population_specificity": "A 35-year-old Indigenous woman with a history of drug and alcohol use, presenting with neuropsychiatric symptoms and fever.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:37.804344+00:00"}
{"study_id": 1904, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of NMDAR antagonists, including ketamine, memantine, and others, in managing neuropathic pain.", "results_summary": "The review suggests that NMDAR antagonists show potential in alleviating neuropathic pain, with varying degrees of efficacy across different agents, but does not provide conclusive results for aspartate specifically.", "population_specificity": "Individuals with neuropathic pain (NeP).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:38.401567+00:00"}
{"study_id": 1905, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effect of D-Asp on growth hormone (GH) secretion in wethers and explore its potential pathways of action.", "results_summary": "High and low doses of D-Asp increased blood GH concentrations and reduced plasma insulin levels, while NEFA concentrations rose post-infusion. D-Asp also showed a non-significant direct stimulatory effect on GH secretion in cultured pituitary tissues.", "population_specificity": "Wethers (castrated male sheep)", "effective_dosage": "High-dose (0.1 mmol/kg/min) and low-dose (0.05 mmol/kg/min) intravenous infusions", "study_duration": "20 minutes", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:40.093808+00:00"}
{"study_id": 1909, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers aimed to report a rare case of cerebral venous sinus thrombosis following rituximab treatment in a patient with anti-N-methyl-D-aspartate receptor-antibody encephalitis.", "results_summary": "The study found that a 15-year-old girl with anti-N-methyl-D-aspartate receptor-antibody encephalitis developed cerebral venous sinus thrombosis after rituximab treatment, despite no underlying prothrombotic state, and recovered with anticoagulation.", "population_specificity": "15-year-old Sri Lankan girl with anti-N-methyl-D-aspartate receptor-antibody encephalitis.", "effective_dosage": "Four doses of rituximab at weekly intervals.", "study_duration": "Four weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:42.449692+00:00"}
{"study_id": 1910, "supplement_id": 895, "safety_score": "85", "efficacy_score": 78, "quality_score": 72, "study_goal": "The researchers aimed to evaluate the anti-epileptic activity of novel benzopyridazine compounds targeting the N-Methyl D-Aspartate glutamate receptor.", "results_summary": "Compounds 6a and 6c showed higher binding energy and PI values than phenytoin, indicating better efficacy and safety potential. The synthesized compounds had yields of 88-96% and demonstrated significant antiepileptic activity in both in-silico and in vivo tests.", "population_specificity": "Not specified (in-silico and in vivo animal models implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:43.065007+00:00"}
{"study_id": 1907, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether higher levels of NMDAR antibodies contribute to sensory gating deficits in schizophrenia.", "results_summary": "The study found that patients with first-episode schizophrenia had higher serum NMDAR antibody levels, which correlated with impaired sensory gating (higher P50 ratio and lower P50 difference). These findings suggest NMDAR autoimmunity may play a role in sensory gating deficits in schizophrenia.", "population_specificity": "72 non-smoking inpatients with first-episode schizophrenia and 51 non-smoking healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:43.127602+00:00"}
{"study_id": 1912, "supplement_id": 895, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of rituximab for treating anti-NMDAR encephalitis in children without tumors who were refractory to first-line treatments.", "results_summary": "Rituximab significantly reduced mRS scores and CD19+ B cells after four weeks, with 77.8% of patients achieving complete recovery. Adverse events were mild and transient, with no severe incidents reported.", "population_specificity": "Pediatric patients with anti-NMDAR encephalitis and no tumor.", "effective_dosage": "Not specified (rituximab administered 3.2 \u00b1 1.0 days after IVIG and methylprednisolone).", "study_duration": "Initial treatment for four weeks, with follow-up averaging 44.1 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:44.246840+00:00"}
{"study_id": 1913, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers aimed to describe the clinical presentation, diagnostic challenges, and treatment approach for a patient with autoimmune NMDA receptor encephalitis.", "results_summary": "The study reported a patient with NMDA receptor encephalitis who exhibited psychosis, memory disturbances, seizures, and autonomic instability, reflecting the disorder's characteristic progression.", "population_specificity": "A single patient with autoimmune NMDA receptor encephalitis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:44.791530+00:00"}
{"study_id": 1911, "supplement_id": 895, "safety_score": "90", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of lithium aspartate therapy on fatigue and cognitive dysfunction in patients with neurologic post-COVID-19 condition (PCC).", "results_summary": "The study found that lithium aspartate at 10-15 mg/d was ineffective for treating neurologic PCC symptoms, with no significant intergroup differences. Higher dosages (40-45 mg/d) showed numerically greater reductions in symptoms in a small subset of patients, but further RCTs are needed to confirm these findings.", "population_specificity": "Adults with neurologic PCC symptoms (fatigue or cognitive dysfunction persisting >4 weeks post-COVID-19 infection).", "effective_dosage": "10-15 mg/d (initial RCT), up to 45 mg/d (dose-finding study).", "study_duration": "3 weeks (RCT), followed by 6 weeks (dose-finding study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:45.159572+00:00"}
{"study_id": 1914, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of tropisetron on PTZ-induced seizures in mice, exploring its potential role in NMDA receptor inhibition and inflammatory responses.", "results_summary": "Tropisetron showed dose-dependent anticonvulsant effects at 5 and 10 mg/kg, enhanced by NMDA receptor antagonists, and reduced hippocampal TNF-\u03b1 levels, indicating anti-inflammatory potential.", "population_specificity": "Mice with PTZ-induced seizures", "effective_dosage": "1, 2, 3, 5, and 10 mg/kg tropisetron, administered intraperitoneally", "study_duration": "Single-dose intervention (30 minutes before PTZ)", "interactions": "Enhanced anticonvulsant effect when combined with NMDA receptor antagonists (ketamine and MK-801)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:47.181641+00:00"}
{"study_id": 1915, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers aimed to document a rare case of anti-NMDAR encephalitis caused by a paraneoplastic effect from an ovarian dermoid cyst, highlighting the role of N-methyl-D-aspartate receptor (NMDAR) antibodies.", "results_summary": "The study found that an ovarian dermoid cyst produced NMDAR antibodies, leading to anti-NMDAR encephalitis with neuropsychiatric symptoms such as confusion, hallucinations, and cognitive changes in a 39-year-old female patient. The diagnosis was confirmed through imaging and physician consults.", "population_specificity": "39-year-old female with encephalitis, headaches, and auditory hallucinations.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:48.239536+00:00"}
{"study_id": 1916, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers aimed to characterize the response of adult patients with intrathecal methotrexate (MTX) neurotoxicity to dextromethorphan treatment.", "results_summary": "The study found that dextromethorphan treatment led to neurologic symptom resolution within 1 to 2 days in adult patients with suspected MTX neurotoxicity. Radiologic phenotypes included subcortical white matter abnormalities.", "population_specificity": "Adult patients with intrathecal MTX neurotoxicity (n=4).", "effective_dosage": "Not specified", "study_duration": "Treatment duration until symptom resolution (1-2 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:50.411692+00:00"}
{"study_id": 1917, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to demonstrate the protective effects of Chaihu Guizhi Decoction (CGD) in an animal model of anti-NMDAR encephalitis and explore its potential mechanisms.", "results_summary": "CGD alleviated cognitive, memory, and sensorimotor gating deficits in mice treated with anti-NMDAR encephalitis patients' antibodies. It prevented NMDAR reduction in vitro and in vivo and regulated NMDAR-interacting proteins and dopamine receptors.", "population_specificity": "Mice treated with anti-NMDAR encephalitis patients' antibodies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:51.392440+00:00"}
{"study_id": 1918, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the utility of NMDA receptor antagonists (including amantadine, memantine, ketamine, and esketamine) as alternatives to benzodiazepines in treating catatonia in adults.", "results_summary": "The study found that amantadine and memantine showed quick responses in treating catatonia, either as monotherapy or adjunctive therapy with benzodiazepines. Ketamine and esketamine also demonstrated potential, though evidence was limited to a small number of cases.", "population_specificity": "Adults with catatonia, particularly those partially or non-responsive to benzodiazepines or with contraindications like co-morbid delirium.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:51.993683+00:00"}
{"study_id": 1920, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine if serum neuron-specific enolase (NSE) concentration is associated with clinical features and prognosis in anti-NMDAR encephalitis.", "results_summary": "Serum NSE concentrations were significantly higher in anti-NMDAR encephalitis patients compared to controls and correlated with disease severity, poor treatment response, and worse prognosis. Higher NSE levels were linked to brain damage indicators like lesions, atrophy, and critical clinical symptoms.", "population_specificity": "58 anti-NMDAR encephalitis cases, 58 matched healthy controls, and 58 matched disease controls.", "effective_dosage": "Not specified", "study_duration": "Follow-up assessments up to one year after onset.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:53.051300+00:00"}
{"study_id": 1921, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the long-term cognitive, psychiatric, psychological, and social outcomes in patients with NMDAR encephalitis, intending to improve patient care and awareness of the disease's psychosocial consequences.", "results_summary": "The study did not directly assess Aspartate's effects but focused on understanding the long-term impacts of NMDAR encephalitis through qualitative interviews, standardized questionnaires, neuropsychological examinations, and online surveys. It aims to develop structured interviews, survey questions, and treatment guidelines to enhance patient-centered care.", "population_specificity": "Patients with NMDAR encephalitis and their caregivers.", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:53.224200+00:00"}
{"study_id": 1919, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare NMDAR autoantibody levels in children with intractable versus non-intractable epilepsy to assess its association with epilepsy severity.", "results_summary": "NMDAR autoantibody levels were numerically higher in intractable epilepsy (41.3%) than non-intractable epilepsy (33.4%), but the difference was not statistically significant (P=0.157). Seizure frequency correlated with autoantibody positivity (P=0.002), but ASM use did not (P>0.05).", "population_specificity": "Children aged 1 month to 18 years diagnosed with epilepsy and receiving anti-seizure medication therapy.", "effective_dosage": "Not specified", "study_duration": "Study conducted from June to September 2022 (duration not explicitly stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:53.435830+00:00"}
{"study_id": 1922, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate the familiarity of Romanian psychiatrists with anti-NMDAR encephalitis, including their awareness of clinical features, differential diagnoses, and treatment options.", "results_summary": "The study found that Romanian psychiatrists had suboptimal knowledge of anti-NMDAR encephalitis, with only 2.7% having comprehensive knowledge. Higher awareness levels and prior case encounters significantly influenced answer accuracy regarding psychiatric presentation and epidemiological features.", "population_specificity": "Romanian psychiatrists (111 participants, including specialists and trainees).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:54.694400+00:00"}
{"study_id": 1923, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of L-Ornithine-L-Aspartate (LOLA) to improve perfusion and angiogenesis in a rat model of hind limb ischemia, as a potential treatment for peripheral arterial disease (PAD).", "results_summary": "LOLA administration significantly increased perfusion, capillary density (CD31-positive), and VEGF expression in the ischemic limb during the subacute phase of hind limb ischemia compared to control and sorbitol groups.", "population_specificity": "Rat model with induced hind limb ischemia (7 rats per group).", "effective_dosage": "Intraperitoneal injections administered five times on post-operative days 3, 5, 7, 10, and 12 (exact dosage not specified).", "study_duration": "Intervention administered over 12 days post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:58.579818+00:00"}
{"study_id": 1925, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the efficacy of NMDA receptor antagonists, including compounds like HU-211 and NPS 150, in reducing brain edema and improving neurobehavioral outcomes in rodent models of traumatic brain injury.", "results_summary": "NMDA antagonists significantly reduced brain edema (SMD -1.17, p < 0.01) and improved Neurobehavioral Severity Scale scores (mean difference -3.32, p < 0.01), with administration within 1 hour post-injury showing enhanced effects.", "population_specificity": "Sprague-Dawley or Sabra rats with traumatic brain injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:59.818182+00:00"}
{"study_id": 1926, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of outpatient rehabilitation, including interferential current stimulation and resistance exercises, in managing prolonged dysphagia in a patient with anti-N-methyl-d-aspartate receptor encephalitis.", "results_summary": "The study found that combined treatment with interferential current stimulation and resistance exercises led to significant improvement in chronic dysphagia in the patient. The results highlight the potential efficacy of this rehabilitation approach for similar cases.", "population_specificity": "A single patient with anti-N-methyl-d-aspartate receptor encephalitis and prolonged dysphagia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:01.125386+00:00"}
{"study_id": 1931, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to assess blood serum levels of aspartate and other glutamatergic amino acids in patients with schizophrenia (SCZ) and autism spectrum disorder (ASD) compared to controls.", "results_summary": "The study found reduced D-aspartate serum levels in SCZ patients compared to controls, but no significant differences in aspartate levels were observed in ASD patients.", "population_specificity": "Patients with schizophrenia (subdivided into treatment-resistant and non-treatment-resistant) and autism spectrum disorder, along with control subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:01.170179+00:00"}
{"study_id": 1928, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the biosynthetic pathways of aspartate, its metabolic roles, and potential therapeutic targeting in proliferating cells, particularly in tumors and bone marrow.", "results_summary": "The abstract highlights that aspartate is produced endogenously via GOT1/GOT2 or salvaged from the microenvironment, discusses conditions favoring its uptake, and explores its metabolic functions and potential as a cancer therapy target.", "population_specificity": "Proliferating cells, particularly in tumors and bone marrow (based on available data).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:01.170889+00:00"}
{"study_id": 1927, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify predictors of poor short-term prognosis after first-line immunotherapy in patients with anti-NMDAR encephalitis and develop a prognostic prediction model.", "results_summary": "The study found that poor short-term prognosis was a significant risk factor for poor long-term outcomes, with specific clinical and laboratory factors (e.g., abnormal behavior, consciousness impairment, CSF pleocytosis) independently predicting poor short-term prognosis. A nomogram incorporating these factors showed strong discrimination and calibration (AUC 0.866).", "population_specificity": "Patients diagnosed with anti-NMDAR encephalitis across five clinical centers in China.", "effective_dosage": "Not specified", "study_duration": "Follow-up periods included 6, 12, and 24 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:01.859084+00:00"}
{"study_id": 1932, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how bright light exposure mitigates cognitive deficits associated with schizophrenia by examining its impact on hippocampal neurogenesis in mice.", "results_summary": "Bright light exposure increased proliferating and immature neurons in the dentate gyrus and lateral ventricle of MK-801-treated mice, promoting neurogenesis and attenuating cognitive deficits in behavioral tests. These effects suggest a potential noninvasive approach for cognitive impairments in neuropsychiatric disorders.", "population_specificity": "Juvenile mice (5-8 weeks old) treated with MK-801 to model schizophrenia-like cognitive deficits.", "effective_dosage": "Not specified (bright light exposure only).", "study_duration": "Three weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:03.647432+00:00"}
{"study_id": 1934, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to highlight the importance of timely diagnosis and management of NMDAR encephalitis in pediatric patients to prevent long-term complications.", "results_summary": "The study found that a 14-year-old female with anti-NMDAR encephalitis showed no improvement under viral encephalitis treatment but demonstrated notable recovery after immunosuppressive therapy following confirmation of autoimmune etiology via cerebrospinal fluid antibody assay.", "population_specificity": "14-year-old female pediatric patient with anti-NMDAR encephalitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:06.497274+00:00"}
{"study_id": 1935, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether ornithine aspartate (LOLA) could improve oxidative stress, thyroid hormone metabolism dysfunction, and liver health in a rat model of metabolic dysfunction associated with steatotic liver disease (MASLD).", "results_summary": "LOLA reduced collagen deposition, oxidative stress markers, and improved thyroid hormone metabolism and mitochondrial function. It also normalized enzyme activities and reduced endoplasmic reticulum stress.", "population_specificity": "Adult Sprague-Dawley rats with induced MASLD.", "effective_dosage": "200 mg/kg/day of LOLA.", "study_duration": "12 weeks (from weeks 16 to 28).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:08.146428+00:00"}
{"study_id": 1936, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether L-aspartate supplementation could alleviate liver fibrosis by rebalancing cholesterol-steroid metabolism and suppressing GR\u03b2 signaling.", "results_summary": "L-aspartate supplementation reduced liver injury and fibrosis in CCl4-induced fibrotic mice, improved mitochondrial function, and rebalanced hepatic cholesterol-steroid metabolism by suppressing GR\u03b2 signaling.", "population_specificity": "CCl4-induced fibrotic mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:08.473506+00:00"}
{"study_id": 1938, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the distinct roles of GluN2A and GluN2B subtypes of NMDAR in mediating peripheral sensitization and inflammatory allodynia during TMJ inflammation.", "results_summary": "The study found that CFA-induced mechanical allodynia was relieved in GluN2A and GluN2B deficient mice, and NMDAR regulated gap junction proteins through specific intracellular signaling pathways, highlighting potential therapeutic targets for orofacial inflammatory allodynia.", "population_specificity": "Mice with TMJ inflammation induced by CFA injection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:09.207454+00:00"}
{"study_id": 1924, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to report a case of anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) induced by HSV2E and evaluate the effectiveness of IVIG monotherapy.", "results_summary": "The study found that IVIG monotherapy was effective in treating NMDARE induced by HSV2E, with the patient showing a favorable response. It highlights the importance of considering autoimmune encephalitis post-HSV2E and the utility of mNGS for diagnosis.", "population_specificity": "A single immunocompetent adult Chinese patient with HSV2E-induced NMDARE.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:09.650246+00:00"}
{"study_id": 1937, "supplement_id": 895, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess the safety, tolerability, and clinical pharmacology of dalzanemdor (SAGE-718), an NMDAR PAM, for potential treatment of cognitive impairment in disorders like Huntington's and Alzheimer's disease.", "results_summary": "Dalzanemdor was well tolerated with no adverse events leading to discontinuation, exhibited suitable pharmacokinetics for once-daily dosing, and showed potential cognitive improvement in HD participants.", "population_specificity": "Healthy participants and Huntington's disease (HD) participants.", "effective_dosage": "Single doses (0.35, 0.75, 1.5, 3.0 mg) and multiple doses (0.5, 1.0 mg daily).", "study_duration": "Single-dose study and 14-day multiple-dose study.", "interactions": "Exposure decreased slightly with food.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:10.665308+00:00"}
{"study_id": 1939, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of N-methyl-D-aspartate glutamate receptors (NMDAR) in alcohol use disorder (AUD) and assess the potential of aerobic exercise as an adjunctive therapy by modulating NMDAR activity.", "results_summary": "The study found that NMDAR levels are implicated in AUD's emotional and behavioral effects, and aerobic exercise may modulate NMDAR activity, suggesting its potential as an adjunctive therapy for AUD. Clinical and basic science studies support the role of exercise in influencing reward-linked receptors via NMDA signaling.", "population_specificity": "Individuals with alcohol use disorder (AUD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:10.983428+00:00"}
{"study_id": 1940, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the expression of aspartate-\u03b2-hydroxylase (ASPH) and hypoxia markers in head and neck squamous cell carcinomas (HNSCCs) and their association with HPV status and patient prognosis.", "results_summary": "The study found higher expression of ASPH and hypoxia markers (HIF1A, GLUT1, MMP13) in HPV-positive HNSCCs, which are typically linked to poor prognosis but may indicate active HPV infection. Increased HIF1A and GLUT1 expression were associated with better survival outcomes, independent of HPV status.", "population_specificity": "Patients with head and neck squamous cell carcinomas (HNSCCs), both HPV-positive and HPV-negative.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:12.790322+00:00"}
{"study_id": 1941, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the antidepressant mechanisms of ketamine, focusing on its role as an NMDAR antagonist and exploring controversies around its NMDAR-dependent and independent actions.", "results_summary": "The study found that ketamine, as an NMDAR antagonist, exhibits rapid and potent antidepressant effects compared to traditional monoamine-targeting antidepressants, though clinical results of other NMDAR inhibitors remain controversial. The abstract highlights both NMDAR-dependent and independent mechanisms contributing to ketamine's antidepressant action.", "population_specificity": "Not specified (general discussion of clinical and preclinical evidence).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:14.870647+00:00"}
{"study_id": 1942, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of electroconvulsive therapy (ECT) in patients with N-methyl-d-aspartate receptor encephalitis (NMDARE).", "results_summary": "The study found mixed results, with clinical improvement attributed to ECT in 49% of patients in the scoping review and 19% in the retrospective cohort, but worsening of symptoms occurred in 28% and 38% of patients, respectively. The data was insufficient to support a beneficial effect of ECT in NMDARE.", "population_specificity": "Patients diagnosed with N-methyl-d-aspartate receptor encephalitis (NMDARE).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:16.651609+00:00"}
{"study_id": 1944, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify metabolic adaptations in T-ALL cells, particularly the role of glutamine-derived aspartate in nucleotide synthesis and its potential as a therapeutic target.", "results_summary": "The study found that glutamine-derived aspartate is crucial for nucleotide synthesis in T-ALL cells, and the glutamate-aspartate transporter EAAT1 (SLC1A3) is essential for this process, making it a novel therapeutic target.", "population_specificity": "T-cell acute lymphoblastic leukemia (T-ALL) patients, both pediatric and adult.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:17.353546+00:00"}
{"study_id": 1943, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze the influence of ornithine aspartate (LOLA) on gut microbiota in a nutritional model of metabolic-dysfunction associated steatotic liver disease (MASLD).", "results_summary": "LOLA did not affect alpha and beta diversity but was associated with changes in specific gut microbes (Helicobacter rodentium, Parabacteroides goldsteinii, and Parabacteroides distasonis) and altered metabolic pathways related to energy, nucleotide biosynthesis, and lipid metabolism.", "population_specificity": "Adult male Sprague Dawley rats fed a high-fat and choline-deficient diet.", "effective_dosage": "200 mg/kg/d LOLA", "study_duration": "12 weeks (administered after the 16th week of diet intervention, total study duration 28 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:17.856379+00:00"}
{"study_id": 1946, "supplement_id": 895, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "To analyze the clinical features and outcomes of children with refractory NMDA receptor antibody encephalitis treated with tocilizumab.", "results_summary": "Tocilizumab improved symptoms (movement disorder, sleep disorder, consciousness disorder, silence, autonomic dysfunction) in all 9 children, with no seizures reported at follow-up. Modified Rankin scale scores significantly improved, and no serious adverse reactions were observed.", "population_specificity": "9 children (6 male, 3 female) with refractory NMDA receptor antibody encephalitis, aged 2.8\u20138.7 years at onset.", "effective_dosage": "Treatment frequency was 8 (5, 13) times (specific dosage not provided).", "study_duration": "Follow-up time was 2.8 (1.5, 3.7) years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:18.980441+00:00"}
{"study_id": 1948, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to describe a case of NMDAR antibody encephalopathy in a young female and evaluate the clinical presentation and treatment outcomes.", "results_summary": "The study found that a young female with NMDAR antibody encephalopathy presented with severe neurological and psychiatric symptoms, including hallucinations and agitation. After treatment, she showed complete resolution of symptoms at the two-month follow-up.", "population_specificity": "Young female with no significant past medical, psychological, or surgical history.", "effective_dosage": "Not mentioned", "study_duration": "Two-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:19.261950+00:00"}
{"study_id": 1947, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine if the aspartate transaminase-to-albumin ratio (ATAR) could serve as an independent prognostic factor for overall survival in small cell lung cancer (SCLC) patients.", "results_summary": "The study found that elevated ATAR was an independent adverse predictor of overall survival in SCLC patients, with high-risk ATAR groups showing significantly lower survival rates. ATAR outperformed other prognostic markers (ALB, PNI, SII) and combined models with these markers enhanced prognostic value.", "population_specificity": "196 SCLC patients from Sichuan Cancer Hospital (December 2013 to September 2022), including smokers (55.6%).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 17.55 months (overall survival).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:20.411168+00:00"}
{"study_id": 1949, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a sensitive LC-MS/MS-based method for quantifying N-acetylaspartate in dried blood spots to enable early postnatal diagnosis of Canavan disease.", "results_summary": "The study successfully developed a novel test that clearly differentiated Canavan patients from controls based on N-acetylaspartate concentrations, with no overlap between groups. The method showed high sensitivity and potential for newborn screening.", "population_specificity": "Neonates and older controls, including 25 Canavan patients (8 with neonatal samples) and 59 older controls, plus 784 neonatal controls.", "effective_dosage": "Not applicable (diagnostic method, not intervention).", "study_duration": "Not applicable (diagnostic study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:21.992354+00:00"}
{"study_id": 1950, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the relevance of anti-NMDAR encephalitis for psychiatrists, including its connection to schizophrenia, diagnostic challenges, psychiatric features, and treatment outcomes.", "results_summary": "The study highlights the importance of psychiatrists recognizing anti-NMDAR encephalitis, discusses its psychiatric manifestations, and critiques early diagnostic criteria while exploring potential specific psychiatric phenotypes for early diagnosis.", "population_specificity": "Patients with anti-NMDAR encephalitis, particularly those presenting with psychiatric symptoms.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:22.883613+00:00"}
{"study_id": 1953, "supplement_id": 895, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to identify additional molecular targets of L-ornithine-L-aspartate (LOLA) and assess its potential as a treatment for non-alcoholic fatty liver disease (NAFLD).", "results_summary": "LOLA reduced toxic ammonium levels, improved urea cycle enzyme activity, modulated fatty acid metabolism genes, and restored mitochondrial function in NAFLD models. It also increased expression of branched-chain amino acid enzymes and favorably affected energy balance regulators.", "population_specificity": "Primary hepatocytes from NAFLD patients and HepG2 hepatoblastoma cells (including models of steatosis, insulin resistance, and metabolic syndrome).", "effective_dosage": "\u226440 mM LOLA (concentration-dependent effects observed).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:25.481814+00:00"}
{"study_id": 1954, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the bidirectional regulation of NMDA function using dimethyl malonate (DMM) and dodecagalloyl-\u03b1-D-xylose (\u03b112G) to modulate D-serine levels and improve symptoms in CNS disorders with NMDA hypofunction.", "results_summary": "DMM unexpectedly increased D-serine levels, while \u03b112G enhanced racemization activity of human SR and improved behavioral symptoms in animal models of CNS disorders with NMDA hypofunction.", "population_specificity": "C57BL/6J male mice", "effective_dosage": "400 mg/kg DMM (intravenous)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:25.675600+00:00"}
{"study_id": 1955, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to describe a rare case of FLAMES combined with anti-NMDARE and explore the clinical features and immune mechanisms of MNOS overlap syndrome.", "results_summary": "The study reported a case of FLAMES with anti-NMDARE, initially misdiagnosed as viral encephalitis, which responded well to high-dose corticosteroids. It highlights the importance of testing for autoantibodies to avoid misdiagnosis and emphasizes steroid responsiveness in MNOS.", "population_specificity": "A 29-year-old male with seizures and atypical MRI findings.", "effective_dosage": "High-dose corticosteroids (specific dosage not mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:26.182686+00:00"}
{"study_id": 1956, "supplement_id": 895, "safety_score": "30", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to determine the roles of N-Methyl-D-Aspartate agonists (MK-801) and Thymoquinone on mitochondria and apoptosis in colon cancer treatment.", "results_summary": "The study found that both TQ and MK-801 reduced cell viability and induced apoptosis and mitochondrial dysfunction in HT-29 cells, with effects dependent on dosage. The study highlights potential toxicity risks, emphasizing the need for further safety evaluation.", "population_specificity": "HT-29 colon cancer cells (in vitro study).", "effective_dosage": "Different concentrations of TQ and MK-801 (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:27.725259+00:00"}
{"study_id": 1957, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify potent inhibitors of human aspartate transcarbamoylase (ATC) for potential cancer therapy by screening a library of ATC inhibitors.", "results_summary": "Four compounds showed low nanomolar inhibition of human ATC, outperforming the previously tested PALA, and suppressed osteoblastoma cell proliferation by inducing cell cycle arrest. The study also identified a druggable allosteric pocket in human ATC.", "population_specificity": "In vitro assays and U2OS osteoblastoma cells.", "effective_dosage": "IC50 values of 30-120 nM for the inhibitors.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:27.966995+00:00"}
{"study_id": 1958, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the allosteric regulation of aspartate kinase (WBmAK) from Wolbachia endosymbiont of Brugia malayi to inform structure-based drug discovery.", "results_summary": "The study found that ATP and aspartate binding promote enzymatic activity by inducing a closed conformation, while lysine acts as a potent allosteric inhibitor, causing enzyme inactivation and an open conformation. WBmAK showed optimal activity at 28\u00b0C and pH 8.0.", "population_specificity": "Microbial (Wolbachia endosymbiont of Brugia malayi)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:28.853200+00:00"}
{"study_id": 1959, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if cerebral N-acetyl aspartate (NAA) concentrations decrease progressively in Major Depressive Disorder (MDD) patients compared to healthy controls.", "results_summary": "NAA concentrations were significantly reduced in chronic MDD patients compared to healthy controls in several brain regions, including the frontal lobe, occipital lobe, thalamus, and white matter. Antidepressant treatment may reverse NAA alterations in the frontal lobe.", "population_specificity": "Chronic MDD patients (n=1308), first-episode depression patients (n=242), and healthy controls (n=1242).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:30.462139+00:00"}
{"study_id": 1960, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to improve the diagnosis and treatment of anti-N-methyl-D-aspartate receptor encephalitis in people living with HIV (PLWH).", "results_summary": "The study highlights the importance of early recognition and treatment of autoimmune encephalitis in PLWH to prevent severe outcomes like seizures or coma. It reviews clinical characteristics and reports a case from their center, emphasizing the challenges of immunosuppressive therapy in this population.", "population_specificity": "People living with HIV (PLWH) showing abnormal behavior, cognitive impairment, or abnormal movements.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:32.287749+00:00"}
{"study_id": 1961, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the relationship between perioperative factors affecting NMDA receptor functionality and the onset of postoperative cognitive dysfunction (POCD).", "results_summary": "The study found that NMDA receptor dysfunction, influenced by aging, anesthetic use, surgical stress, inflammation, and pain, plays a significant role in POCD development. It suggests targeting NMDA receptor-related pathways could improve postoperative outcomes.", "population_specificity": "Patients undergoing surgery, particularly focusing on aging populations and those exposed to perioperative stressors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:33.316406+00:00"}
{"study_id": 201862, "supplement_id": 895, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the tolerability and efficacy of L-serine (not Aspartate) in children with GRIN loss-of-function genetic variants.", "results_summary": "L-serine showed significant improvements in adaptive behavior, motor function, and quality of life, particularly in mild phenotypes, with one discontinuation due to irritability and insomnia. EEG normalization and seizure frequency reduction were also observed in some patients.", "population_specificity": "Children aged 2-18 years with GRIN2B, GRIN1, or GRIN2A loss-of-function pathogenic variants, presenting with intellectual disability, behavioral problems, movement disorders, or epilepsy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "52 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:34.906942+00:00"}
{"study_id": 1962, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to document a case of anti-NMDAR encephalitis, its clinical presentation, treatment response, and the delayed diagnosis of an associated ovarian teratoma.", "results_summary": "The patient showed significant clinical improvement after treatment with high-dose intravenous steroids, IVIg, and rituximab, with resolution of neurologic symptoms. A delayed diagnosis of ovarian teratoma was made years later, highlighting the importance of surveillance imaging in high-risk patients.", "population_specificity": "25-year-old female with anti-NMDAR encephalitis.", "effective_dosage": "High-dose intravenous steroids, IVIg, and rituximab infusion (specific dosages not detailed).", "study_duration": "Treatment duration not specified; follow-up spanned two years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:35.366604+00:00"}
{"study_id": 201863, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of aspartate supplementation on repeated-sprint performance and blood pH in healthy males.", "results_summary": "Aspartate supplementation significantly increased plasma aspartate concentration during exercise and improved peak cadence in the second sprint set compared to placebo. No significant differences in blood pH were reported.", "population_specificity": "Fourteen healthy males.", "effective_dosage": "4.5 g taken twice on each test day (total 9 g/day).", "study_duration": "Single-day intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:35.435311+00:00"}
{"study_id": 201864, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the impact of onion supplementation on metabolic health parameters, including aspartate aminotransferase (AST) levels.", "results_summary": "Onion supplementation significantly improved AST levels, particularly at dosages >300 mg/day and in interventions lasting more than 12 weeks.", "population_specificity": "Participants in randomized controlled trials (RCTs) included in the meta-analysis.", "effective_dosage": ">300 mg/day", "study_duration": "More than 12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:36.118879+00:00"}
{"study_id": 201867, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the role of Reelin in neuronal migration during brain development and its regulatory function in the adult brain.", "results_summary": "The study found that Reelin, produced mainly in Cajal-Retzius cells, controls neuronal migration critical for cortical layer formation during brain development and plays a crucial regulatory role in the adult brain.", "population_specificity": "Not specified (focus on brain development and adult brain function).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:38.401243+00:00"}
{"study_id": 201866, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of the cholinergic system, including N-methyl-d-aspartate (NMDA) antagonists like memantine, in Alzheimer's disease therapy and explore new cholinergic therapeutic approaches.", "results_summary": "The study highlights memantine, an NMDA antagonist, as effective for behavioral symptoms in Alzheimer's disease, often combined with cholinesterase inhibitors. It also discusses new M1 muscarinic receptor agonists and a nerve growth factor pathway with disease-modifying potential.", "population_specificity": "Patients with Alzheimer's disease (early and late stages).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:38.459953+00:00"}
{"study_id": 201869, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to characterize transcriptional changes in liver tissue across the NAFLD spectrum and identify potential circulating markers, including aspartate aminotransferase (AST).", "results_summary": "The study identified differences in AST levels associated with disease activity and fibrosis stage in NAFLD patients, suggesting its potential as a marker for disease progression.", "population_specificity": "206 patients with histologically characterized NAFLD.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:40.888697+00:00"}
{"study_id": 201871, "supplement_id": 895, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of Nigella sativa (N.S) supplementation on liver and kidney parameters.", "results_summary": "The meta-analysis found that N.S supplements significantly reduced alkaline-phosphatase (ALP) levels, with a weighted mean difference of -10.825 U/L (95% CI: -19.658, -1.992; P = 0.016).", "population_specificity": "1,295 participants across 19 trials.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:41.428785+00:00"}
{"study_id": 114630, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to address the need for practical recommendations in managing post-bariatric patients by producing a document for healthcare professionals.", "results_summary": "The study highlights the need for broader dissemination of knowledge on post-bariatric patient management and presents practical recommendations from the EASO/OMTF document.", "population_specificity": "Healthcare professionals (physicians, obstetricians, dieticians, nurses, etc.) managing post-bariatric patients.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:48.979299+00:00"}
